| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC24A5 GABRG1 NAT2 ABCC3 ABCA1 ABCA2 CNNM2 ATP8B4 CACNA2D2 TRPC1 CFTR PEX1 SLC25A26 ABCA9 SLC22A7 RYR1 RYR2 ITPR3 CACNG3 SLC35D1 CACNG2 SCN2A SCN3A OSBPL5 RFT1 CNGA4 ABCC10 SLC27A6 ATG2B SLC26A5 GRID2 APOB CACHD1 SLC47A2 PITPNM1 SLC25A22 SLC6A9 SLC6A12 SLC25A36 KCNT2 SLC15A4 SLC22A4 SLC17A8 LRP5 SLC26A11 SLC26A6 GABRA1 | 5.93e-08 | 1289 | 314 | 47 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 GABRG1 NAT2 ABCC3 ABCA1 ABCA2 CNNM2 CACNA2D2 TRPC1 CFTR SLC25A26 ABCA9 SLC22A7 RYR1 RYR2 ITPR3 CACNG3 SLC35D1 CACNG2 SCN2A SCN3A CNGA4 ABCC10 SLC27A6 SLC26A5 GRID2 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 SLC25A36 KCNT2 SLC15A4 SLC22A4 SLC17A8 LRP5 SLC26A11 SLC26A6 GABRA1 | 3.91e-06 | 1180 | 314 | 40 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 CDH23 ADGRV1 RYR1 RYR2 ITPR3 FAT1 NRXN1 PCDH15 MMP8 FER1L5 PCDHGB3 FAT3 PCDHB11 PCDHB8 CUBN CBLB LDLR PITPNM1 MMRN1 PCDHB18P EGF HMCN1 LRP1 CDH1 CDH2 CDH4 CDH11 | 2.21e-05 | 749 | 314 | 28 | GO:0005509 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC24A5 GABRG1 ABCC3 CNNM2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 ABCC10 SLC26A5 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 2.74e-05 | 758 | 314 | 28 | GO:0015318 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH23 ACVR1 ITGA9 NEO1 NLGN4X NRXN1 AHNAK TLN2 UTRN CNTN2 FN1 ANK3 NLGN4Y ITGA10 LAMA5 EEF2 CD226 TLN1 TMPO ATIC CDH1 CDH2 CDH4 CDH11 | 2.92e-05 | 599 | 314 | 24 | GO:0050839 |
| GeneOntologyMolecularFunction | calcium channel activity | SLC24A5 CACNA2D2 TRPC1 RYR1 RYR2 ITPR3 CACNG3 CACNG2 CNGA4 CACHD1 | 3.78e-05 | 129 | 314 | 10 | GO:0005262 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC24A5 GABRG1 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 GRID2 CACHD1 KCNT2 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 4.32e-05 | 459 | 314 | 20 | GO:0005216 |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCC3 ABCA1 ABCA2 ATP8B4 ABCA9 SLC22A7 OSBPL5 RFT1 SLC27A6 ATG2B APOB PITPNM1 | 6.71e-05 | 196 | 314 | 12 | GO:0005319 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | NAT2 ABCC3 CFTR SLC25A26 SLC22A7 SLC35D1 SLC27A6 SLC26A5 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC17A8 SLC26A11 SLC26A6 | 6.73e-05 | 293 | 314 | 15 | GO:0008514 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A5 ABCC3 ABCA1 ABCA2 CFTR SLC25A26 ABCA9 SLC22A7 SLC35D1 ABCC10 SLC26A5 SLC47A2 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 7.35e-05 | 477 | 314 | 20 | GO:0022804 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCA1 ABCA2 ATP8B4 ERCC6 CFTR PEX1 PSMC5 ABCA9 DHX35 DDX60L ABCC10 SMARCA5 NSF DHX37 SMCHD1 TOR1A MMAA DNAH11 | 7.79e-05 | 441 | 314 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | NAT2 ABCC3 SLC25A26 SLC22A7 SLC27A6 SLC26A5 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC17A8 SLC26A6 | 1.13e-04 | 207 | 314 | 12 | GO:0046943 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.14e-04 | 49 | 314 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCA1 ABCA2 ATP8B4 ERCC6 CFTR PEX1 PSMC5 ABCA9 DHX35 DDX60L RFT1 ABCC10 SLC27A3 APPBP2 SMARCA5 SLC27A6 NSF DHX37 SMCHD1 TOR1A MMAA DNAH11 | 1.18e-04 | 614 | 314 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | NAT2 ABCC3 SLC25A26 SLC22A7 SLC27A6 SLC26A5 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC17A8 SLC26A6 | 1.18e-04 | 208 | 314 | 12 | GO:0005342 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | SLC24A5 CACNA2D2 TRPC1 RYR1 RYR2 ITPR3 CACNG3 CACNG2 CNGA4 CACHD1 | 1.42e-04 | 151 | 314 | 10 | GO:0015085 |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.44e-04 | 123 | 314 | 9 | GO:0030165 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC24A5 GABRG1 CNNM2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 SLC26A5 GRID2 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 1.49e-04 | 793 | 314 | 27 | GO:0015075 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.54e-04 | 33 | 314 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | NAT2 SLC25A26 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 | 2.54e-04 | 105 | 314 | 8 | GO:0015171 |
| GeneOntologyMolecularFunction | channel activity | SLC24A5 GABRG1 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 GRID2 CACHD1 KCNT2 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 2.63e-04 | 525 | 314 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC24A5 SLC25A26 SLC22A7 SLC35D1 SLC26A5 SLC47A2 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 2.66e-04 | 296 | 314 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC24A5 GABRG1 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 GRID2 CACHD1 KCNT2 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 2.70e-04 | 526 | 314 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.87e-04 | 61 | 314 | 6 | GO:1901682 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | GABRG1 ABCC3 CFTR ABCC10 SLC26A5 SLC6A12 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 3.89e-04 | 171 | 314 | 10 | GO:0015103 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 4.26e-04 | 10 | 314 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 5.79e-04 | 11 | 314 | 3 | GO:0008271 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ABCA1 ABCA2 ATP8B4 ERCC6 CFTR PEX1 PSMC5 ABCA9 SEPTIN3 RHOBTB1 MFN2 DHX35 DDX60L ABCC10 SMARCA5 NSF DHX37 SMCHD1 TOR1A MMAA EEF2 RASL11B MMUT DNAH11 | 5.80e-04 | 775 | 314 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | scaffold protein binding | 6.64e-04 | 93 | 314 | 7 | GO:0097110 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 7.32e-04 | 3 | 314 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 7.32e-04 | 3 | 314 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | diazepam binding | 7.32e-04 | 3 | 314 | 2 | GO:0050809 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 7.53e-04 | 46 | 314 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 8.19e-04 | 125 | 314 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 8.75e-04 | 71 | 314 | 6 | GO:0015179 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRG1 CACNA2D2 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A CNGA4 GRID2 CACHD1 KCNT2 GABRA1 | 8.80e-04 | 334 | 314 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 9.12e-04 | 28 | 314 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 9.80e-04 | 13 | 314 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 9.80e-04 | 13 | 314 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A5 CNNM2 CACNA2D2 TRPC1 RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 CACHD1 SLC6A9 SLC6A12 KCNT2 SLC17A8 | 1.18e-03 | 465 | 314 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.23e-03 | 14 | 314 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.35e-03 | 31 | 314 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.45e-03 | 4 | 314 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 1.45e-03 | 4 | 314 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor binding | 1.45e-03 | 4 | 314 | 2 | GO:0070326 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.45e-03 | 4 | 314 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.45e-03 | 4 | 314 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.52e-03 | 32 | 314 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 ABCA1 ABCA2 ATP8B4 ERCC6 CFTR PEX1 PSMC5 ABCA9 SEPTIN3 RHOBTB1 MFN2 DHX35 DDX60L ABCC10 SMARCA5 NSF DHX37 SMCHD1 TOR1A MMAA EEF2 RASL11B MMUT DNAH11 | 1.75e-03 | 839 | 314 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 ABCA1 ABCA2 ATP8B4 ERCC6 CFTR PEX1 PSMC5 ABCA9 SEPTIN3 RHOBTB1 MFN2 DHX35 DDX60L ABCC10 SMARCA5 NSF DHX37 SMCHD1 TOR1A MMAA EEF2 RASL11B MMUT DNAH11 | 1.78e-03 | 840 | 314 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 ABCA1 ABCA2 ATP8B4 ERCC6 CFTR PEX1 PSMC5 ABCA9 SEPTIN3 RHOBTB1 MFN2 DHX35 DDX60L ABCC10 SMARCA5 NSF DHX37 SMCHD1 TOR1A MMAA EEF2 RASL11B MMUT DNAH11 | 1.78e-03 | 840 | 314 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 1.85e-03 | 16 | 314 | 3 | GO:0015116 | |
| GeneOntologyMolecularFunction | floppase activity | 1.85e-03 | 16 | 314 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 2.00e-03 | 57 | 314 | 5 | GO:0120013 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.14e-03 | 35 | 314 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.14e-03 | 35 | 314 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.23e-03 | 85 | 314 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A5 CNNM2 CACNA2D2 TRPC1 RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 | 2.31e-03 | 627 | 314 | 20 | GO:0022890 |
| GeneOntologyMolecularFunction | chloride channel activity | 2.36e-03 | 86 | 314 | 6 | GO:0005254 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activator activity | 2.38e-03 | 36 | 314 | 4 | GO:0030296 | |
| GeneOntologyMolecularFunction | serine-type carboxypeptidase activity | 2.39e-03 | 5 | 314 | 2 | GO:0004185 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.64e-03 | 18 | 314 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 2.64e-03 | 18 | 314 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.73e-03 | 151 | 314 | 8 | GO:0008509 | |
| GeneOntologyMolecularFunction | cadherin binding | CDH23 ACVR1 NEO1 AHNAK ANK3 EEF2 TLN1 TMPO ATIC CDH1 CDH2 CDH4 CDH11 | 2.90e-03 | 339 | 314 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.91e-03 | 120 | 314 | 7 | GO:0008013 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.00e-03 | 188 | 314 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 3.20e-03 | 39 | 314 | 4 | GO:0070325 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC24A5 CACNA2D2 TRPC1 RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN2A SCN3A CNGA4 CACHD1 KCNT2 | 3.21e-03 | 343 | 314 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | ubiquitin ligase complex scaffold activity | 3.55e-03 | 6 | 314 | 2 | GO:0160072 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 3.55e-03 | 6 | 314 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.57e-03 | 193 | 314 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 3.60e-03 | 20 | 314 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.60e-03 | 20 | 314 | 3 | GO:0034185 | |
| GeneOntologyBiologicalProcess | synapse organization | GABRG1 RELN FRMPD4 MYCBP2 CACNA2D2 TSC2 CACNG2 FZD9 NLGN4X NRXN1 SSH1 MFN2 SNX27 TLN2 CNTN2 CBLN3 ANK3 LRRN1 NLGN4Y PCDHB11 PCDHB8 LAMA5 GRID2 SEZ6L2 ACTR2 CRMP1 CHRD LRP5 CDH1 CDH2 GABRA1 | 4.90e-08 | 685 | 309 | 31 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRG1 RELN FRMPD4 MYCBP2 CACNA2D2 TSC2 CACNG2 FZD9 NLGN4X NRXN1 SSH1 PKHD1 MFN2 SNX27 TLN2 CNTN2 CBLN3 FN1 ANK3 LRRN1 NLGN4Y PCDHB11 PCDHB8 LAMA5 GRID2 SEZ6L2 ACTR2 CRMP1 LSR TLN1 LRP1 CHRD LRP5 CDH1 CDH2 CDH4 CDH11 GABRA1 | 7.00e-08 | 974 | 309 | 38 | GO:0034330 |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 1.38e-07 | 56 | 309 | 9 | GO:0001941 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDH23 FAT1 PCDH15 CNTN2 PCDHGB3 FAT3 PCDHB11 PCDHB8 PCDHB18P HMCN1 CDH1 CDH2 CDH4 CDH11 | 1.55e-07 | 187 | 309 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC24A5 GABRG1 ABCC3 KLHL24 RELN PRSS8 CNNM2 CACNA2D2 INPP5K TRPC1 CFTR CDH23 SLC25A26 SLC22A7 RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 ABCC10 PCSK9 TCAF2 ANK3 NSF SLC26A5 GRID2 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 EGF KCNT2 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 HTT GABRA1 | 6.11e-07 | 1374 | 309 | 45 | GO:0006811 |
| GeneOntologyBiologicalProcess | lipid transport | ABCC3 ABCA1 ABCA2 ATP8B4 CFTR ABCA9 SLC22A7 OSBPL5 MFN2 HRH2 RFT1 VPS51 ABCC10 SLC27A3 PCSK9 HNF1A SLC27A6 ATG2B APOB LDLR PITPNM1 VPS13D EGF LRP1 | 7.49e-07 | 506 | 309 | 24 | GO:0006869 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB6 DCHS2 CDH23 TSC2 ACVR1 ADGRV1 ITGA9 NOD2 FAT1 NEO1 NLGN4X NRXN1 PCDH15 PKHD1 TLN2 CNTN2 ANK3 PCDHGB3 DOCK8 NLGN4Y FAT3 PCDHB11 PCDHB8 ITGA10 GRID2 PTPRU CBLB PDIA3 MMRN1 PCDHB18P HMCN1 TLN1 LRP5 CDH1 CDH2 CDH4 CDH11 IL6ST | 8.65e-07 | 1077 | 309 | 38 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.14e-06 | 53 | 309 | 8 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDH23 ACVR1 FAT1 NRXN1 PCDH15 CNTN2 PCDHGB3 FAT3 PCDHB11 PCDHB8 GRID2 PCDHB18P HMCN1 CDH1 CDH2 CDH4 CDH11 | 1.30e-06 | 313 | 309 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRG1 RELN CACNA2D2 TRPC1 PSMC5 TSC2 ITPR3 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 SSH1 HRH2 FER1L5 UTRN CNTN2 GIT1 NLGN4Y STXBP5 PCDHB11 PCDHB8 APBA1 TOR1A GRID2 SLC6A9 SYNGR1 CHRD SLC17A8 CDH1 CDH2 CDH11 HTT GABRA1 LGI1 | 1.69e-06 | 976 | 309 | 35 | GO:0099536 |
| GeneOntologyBiologicalProcess | central nervous system development | MKKS RELN ABCA2 MYCBP2 IFT172 BBS2 KDM6B GDPD5 NLGN4X NRXN1 SCN2A SYNE2 ALDH3A2 VPS51 CNTN2 NDST1 ARHGEF28 LHX4 GIT1 NLGN4Y DHX37 POU1F1 GRID2 CFAP43 SEZ6L2 LDLR PITPNM1 LSR EGF BARHL1 ZNF335 LRP1 CHRD LRP5 ATIC CDH1 CDH2 CDH11 IL6ST HTT | 1.69e-06 | 1197 | 309 | 40 | GO:0007417 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC24A5 GABRG1 ABCC3 KLHL24 RELN PRSS8 CNNM2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 ABCC10 PCSK9 TCAF2 ANK3 SLC26A5 GRID2 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 SLC26A11 SLC26A6 HTT GABRA1 | 1.99e-06 | 1115 | 309 | 38 | GO:0034220 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | MKKS KNTC1 ABCA2 SIGLEC8 INPP5K TSC2 CHEK1 ANKRD27 FZD9 NEO1 CSNK1A1L NRXN1 SSH1 NTM MFN2 FER1L5 NLRC3 PCSK9 SEMA6C SMARCA5 ANK3 FAT3 TEX14 CIT LDLR CRMP1 RHPN2 CST3 RHPN2P1 LRP1 TEN1 CDH1 | 2.48e-06 | 864 | 309 | 32 | GO:0051129 |
| GeneOntologyBiologicalProcess | membrane organization | RELN ABCA1 ABCA2 ATP8B4 SAMD9 SIGLEC8 TSC2 ANKRD27 PLEKHM1 FZD9 SAMD9L NLGN4X NRXN1 SSH1 AHNAK OSBPL5 MFN2 SNX27 RFT1 FER1L5 CNTN2 TMEM126A ANK3 NSF NLGN4Y ATG2B TOR1A TRAPPC8 PITPNM1 PIKFYVE SYNGR1 LRP5 CDH2 | 2.96e-06 | 914 | 309 | 33 | GO:0061024 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRG1 RELN CACNA2D2 PSMC5 TSC2 ITPR3 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 SSH1 HRH2 FER1L5 CNTN2 GIT1 NLGN4Y STXBP5 PCDHB11 PCDHB8 APBA1 TOR1A GRID2 SLC6A9 SYNGR1 CHRD SLC17A8 CDH1 CDH2 CDH11 HTT GABRA1 LGI1 | 4.37e-06 | 931 | 309 | 33 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRG1 RELN CACNA2D2 PSMC5 TSC2 ITPR3 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 SSH1 HRH2 FER1L5 CNTN2 GIT1 NLGN4Y STXBP5 PCDHB11 PCDHB8 APBA1 TOR1A GRID2 SLC6A9 SYNGR1 CHRD SLC17A8 CDH1 CDH2 CDH11 HTT GABRA1 LGI1 | 4.37e-06 | 931 | 309 | 33 | GO:0007268 |
| GeneOntologyBiologicalProcess | lipid localization | ABCC3 ABCA1 ABCA2 ATP8B4 CFTR ABCA9 SLC22A7 OSBPL5 MFN2 HRH2 RFT1 VPS51 ABCC10 SLC27A3 PCSK9 HNF1A SLC27A6 ATG2B APOB LDLR PITPNM1 VPS13D EGF LRP1 | 5.06e-06 | 565 | 309 | 24 | GO:0010876 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRG1 RELN CACNA2D2 PSMC5 TSC2 ITPR3 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 SSH1 HRH2 FER1L5 CNTN2 GIT1 NLGN4Y STXBP5 PCDHB11 PCDHB8 APBA1 TOR1A GRID2 SLC6A9 SYNGR1 CHRD SLC17A8 CDH1 CDH2 CDH11 HTT GABRA1 LGI1 | 5.23e-06 | 939 | 309 | 33 | GO:0099537 |
| GeneOntologyBiologicalProcess | cholesterol transport | ABCA1 ABCA2 CFTR OSBPL5 VPS51 PCSK9 HNF1A APOB LDLR EGF LRP1 | 5.72e-06 | 134 | 309 | 11 | GO:0030301 |
| GeneOntologyBiologicalProcess | sterol transport | ABCA1 ABCA2 CFTR OSBPL5 VPS51 PCSK9 HNF1A APOB LDLR EGF LRP1 | 8.14e-06 | 139 | 309 | 11 | GO:0015918 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | RELN CACNA2D2 PSMC5 ITPR3 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 SSH1 HRH2 FER1L5 CNTN2 GIT1 NLGN4Y STXBP5 APBA1 GRID2 SLC6A9 SYNGR1 CHRD CDH1 CDH2 CDH11 HTT LGI1 | 8.46e-06 | 663 | 309 | 26 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | RELN CACNA2D2 PSMC5 ITPR3 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 SSH1 HRH2 FER1L5 CNTN2 GIT1 NLGN4Y STXBP5 APBA1 GRID2 SLC6A9 SYNGR1 CHRD CDH1 CDH2 CDH11 HTT LGI1 | 8.68e-06 | 664 | 309 | 26 | GO:0099177 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 RELN MYCBP2 CDH23 TSC2 ANKRD27 FAT1 NEO1 CSNK1A1L NRXN1 SSH1 PCDH15 PKHD1 MFN2 HRH2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 STXBP5 FAT3 SLC26A5 LAMA5 NOX4 CFAP43 CPNE5 CIT PRPF40A ACTR2 ZNF335 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 9.69e-06 | 1194 | 309 | 38 | GO:0000902 |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | ABCA1 ABCA2 CFTR OSBPL5 PCSK9 HNF1A APOB CUBN LDLR CYP2R1 LRP1 LRP5 | 1.46e-05 | 176 | 309 | 12 | GO:1902652 |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.50e-05 | 11 | 309 | 4 | GO:0097104 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | NAT2 ABCC3 SLC25A26 SLC22A7 SLC35D1 HRH2 ABCC10 SLC27A3 HNF1A SLC27A6 SLC26A5 APBA1 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC17A8 SLC26A11 SLC26A6 | 1.51e-05 | 410 | 309 | 19 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | NAT2 ABCC3 SLC25A26 SLC22A7 SLC35D1 HRH2 ABCC10 SLC27A3 HNF1A SLC27A6 SLC26A5 APBA1 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC17A8 SLC26A11 SLC26A6 | 1.62e-05 | 412 | 309 | 19 | GO:0015849 |
| GeneOntologyBiologicalProcess | postsynapse organization | RELN FRMPD4 TSC2 FZD9 NLGN4X NRXN1 SSH1 MFN2 SNX27 NLGN4Y LAMA5 GRID2 ACTR2 CRMP1 LRP5 CDH2 | 2.20e-05 | 313 | 309 | 16 | GO:0099173 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 RELN MYCBP2 CDH23 TSC2 ANKRD27 NEO1 NRXN1 PCDH15 MFN2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 STXBP5 FAT3 LAMA5 CIT ACTR2 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 2.47e-05 | 748 | 309 | 27 | GO:0048667 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC24A5 GABRG1 KLHL24 PRSS8 CNNM2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 PCSK9 ANK3 SLC26A5 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 SLC26A11 SLC26A6 HTT GABRA1 | 2.66e-05 | 1017 | 309 | 33 | GO:0098660 |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 3.17e-05 | 13 | 309 | 4 | GO:0097090 | |
| GeneOntologyBiologicalProcess | response to calcium ion | CPNE8 TRPC1 ADGRV1 RYR1 RYR2 ITPR3 CACNG2 NRXN1 PCDH15 CPNE5 HTT | 3.24e-05 | 161 | 309 | 11 | GO:0051592 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | KLHL24 RELN CFTR RYR2 CACNG3 CACNG2 NRXN1 AHNAK UTRN PCSK9 TCAF2 ANK3 SLC6A9 HTT | 3.45e-05 | 256 | 309 | 14 | GO:0032412 |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | ABCA1 ABCA2 CFTR OSBPL5 PCSK9 HNF1A APOB CUBN LDLR LRP1 LRP5 | 3.63e-05 | 163 | 309 | 11 | GO:0008203 |
| GeneOntologyBiologicalProcess | brain development | MKKS RELN IFT172 BBS2 KDM6B GDPD5 NLGN4X NRXN1 SCN2A SYNE2 VPS51 CNTN2 NDST1 GIT1 NLGN4Y DHX37 POU1F1 GRID2 CFAP43 SEZ6L2 PITPNM1 EGF BARHL1 ZNF335 CHRD ATIC CDH1 CDH2 HTT | 4.16e-05 | 859 | 309 | 29 | GO:0007420 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 RELN ERCC6 MYCBP2 CDH23 TSC2 ADGRV1 ANKRD27 GDPD5 NEO1 NRXN1 NTM PCDH15 MFN2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 GIT1 STXBP5 FAT3 DDR2 TOR1A LAMA5 GRID2 CPNE5 CIT ACTR2 CRMP1 ZNF335 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 4.85e-05 | 1285 | 309 | 38 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | KLHL24 RELN CFTR RYR2 CACNG3 CACNG2 NRXN1 AHNAK UTRN PCSK9 TCAF2 ANK3 SLC6A9 HTT | 5.24e-05 | 266 | 309 | 14 | GO:0022898 |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | CACNA2D2 INPP5K CACNG2 FZD9 NRXN1 SSH1 SNX27 TCAF2 ANK3 LRP1 LRP5 CDH1 CDH2 | 6.36e-05 | 237 | 309 | 13 | GO:1905475 |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 6.90e-05 | 47 | 309 | 6 | GO:0045494 | |
| GeneOntologyBiologicalProcess | localization within membrane | RELN CACNA2D2 INPP5K BBS2 TSC2 ANKRD27 CACNG3 CACNG2 FZD9 NRXN1 SSH1 OSBPL5 SNX27 VPS51 TMEM126A TCAF2 ANK3 GIT1 NSF STXBP5 LAMA5 PIKFYVE LRP1 LRP5 CDH1 CDH2 LGI1 | 7.44e-05 | 798 | 309 | 27 | GO:0051668 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC24A5 KLHL24 PRSS8 CFTR SCN2A SCN3A UTRN CNGA4 PCSK9 ANK3 SLC6A9 SLC6A12 SLC22A4 SLC17A8 | 7.49e-05 | 275 | 309 | 14 | GO:0006814 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC24A5 KLHL24 PRSS8 CFTR SCN2A SCN3A UTRN PCSK9 ANK3 SLC6A9 SLC6A12 SLC17A8 | 7.51e-05 | 208 | 309 | 12 | GO:0035725 |
| GeneOntologyBiologicalProcess | sterol metabolic process | ABCA1 ABCA2 CFTR OSBPL5 PCSK9 HNF1A APOB CUBN LDLR LRP1 LRP5 | 7.69e-05 | 177 | 309 | 11 | GO:0016125 |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | KLHL24 RELN ERBB3 PRSS8 INPP5K TRPC1 CFTR RYR2 CACNG3 CACNG2 NRXN1 AHNAK MFN2 UTRN PCSK9 TCAF2 ANK3 SLC26A5 SLC6A9 SLC17A8 SLC26A6 HTT | 8.67e-05 | 589 | 309 | 22 | GO:0034762 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | GABRG1 ABCC3 CFTR ABCC10 TCAF2 SLC26A5 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 1.07e-04 | 153 | 309 | 10 | GO:0098656 |
| GeneOntologyBiologicalProcess | organic anion transport | NAT2 ABCC3 CFTR SLC25A26 SLC22A7 SLC35D1 HRH2 ABCC10 SLC27A3 HNF1A SLC27A6 SLC26A5 APBA1 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC17A8 SLC26A11 SLC26A6 | 1.08e-04 | 515 | 309 | 20 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of cilium beat frequency | 1.28e-04 | 18 | 309 | 4 | GO:0003356 | |
| GeneOntologyBiologicalProcess | head development | MKKS RELN IFT172 BBS2 KDM6B GDPD5 NLGN4X NRXN1 SCN2A SYNE2 VPS51 CNTN2 NDST1 GIT1 NLGN4Y DHX37 POU1F1 GRID2 CFAP43 SEZ6L2 PITPNM1 EGF BARHL1 ZNF335 CHRD ATIC CDH1 CDH2 HTT | 1.35e-04 | 919 | 309 | 29 | GO:0060322 |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRG1 RELN MYCBP2 NLGN4X NRXN1 TLN2 FN1 LRRN1 NLGN4Y PCDHB11 PCDHB8 GRID2 CRMP1 LSR TLN1 LRP1 CDH1 CDH2 CDH4 CDH11 GABRA1 | 1.48e-04 | 569 | 309 | 21 | GO:0034329 |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 RELN ERCC6 MYCBP2 CDH23 TSC2 ADGRV1 ANKRD27 GDPD5 NEO1 NRXN1 NTM PCDH15 MFN2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 GIT1 STXBP5 FAT3 DDR2 TOR1A LAMA5 GRID2 CPNE5 CIT ACTR2 CRMP1 ZNF335 LRP1 RPGR CDH1 CDH2 CDH4 CDH11 HTT LGI1 | 1.65e-04 | 1463 | 309 | 40 | GO:0048666 |
| GeneOntologyBiologicalProcess | alcohol metabolic process | ABCA1 ABCA2 CFTR SHPK OSBPL5 RFT1 ALDH3A2 PCSK9 HNF1A CYP27C1 POU1F1 APOB CUBN LDLR CYP2R1 LRP1 LRP5 | 1.74e-04 | 412 | 309 | 17 | GO:0006066 |
| GeneOntologyBiologicalProcess | brainstem development | 1.76e-04 | 8 | 309 | 3 | GO:0003360 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | KLHL24 RELN CFTR RYR2 CACNG3 CACNG2 NRXN1 AHNAK UTRN PCSK9 TCAF2 ANK3 SLC6A9 HTT | 1.80e-04 | 299 | 309 | 14 | GO:0032409 |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 1.82e-04 | 79 | 309 | 7 | GO:0034394 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 1.86e-04 | 56 | 309 | 6 | GO:0099601 | |
| GeneOntologyBiologicalProcess | intracellular cholesterol transport | 1.88e-04 | 36 | 309 | 5 | GO:0032367 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 RELN MYCBP2 TSC2 ANKRD27 NEO1 NRXN1 MFN2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 STXBP5 LAMA5 CPNE5 CIT ACTR2 ZNF335 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 1.99e-04 | 802 | 309 | 26 | GO:0048812 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | ABCA2 CACNA2D2 INPP5K BBS2 TSC2 CACNG3 CACNG2 NRXN1 SNX27 ANK3 GIT1 NSF LAMA5 LRP1 CDH1 CDH2 LGI1 | 2.31e-04 | 422 | 309 | 17 | GO:1990778 |
| GeneOntologyBiologicalProcess | synapse assembly | GABRG1 RELN MYCBP2 NLGN4X NRXN1 LRRN1 NLGN4Y PCDHB11 PCDHB8 GRID2 CRMP1 CDH1 CDH2 GABRA1 | 2.45e-04 | 308 | 309 | 14 | GO:0007416 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC24A5 KLHL24 PRSS8 CNNM2 CACNA2D2 INPP5K TRPC1 CFTR CDH23 RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 PCSK9 ANK3 NSF CACHD1 SLC6A9 SLC6A12 EGF KCNT2 SLC22A4 SLC17A8 HTT | 2.48e-04 | 1000 | 309 | 30 | GO:0030001 |
| GeneOntologyBiologicalProcess | receptor clustering | 2.48e-04 | 83 | 309 | 7 | GO:0043113 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor catabolic process | 2.62e-04 | 9 | 309 | 3 | GO:2000646 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 RELN MYCBP2 TSC2 ANKRD27 NEO1 NRXN1 MFN2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 STXBP5 LAMA5 CPNE5 CIT ACTR2 ZNF335 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 2.76e-04 | 819 | 309 | 26 | GO:0120039 |
| GeneOntologyBiologicalProcess | intracellular sterol transport | 2.77e-04 | 39 | 309 | 5 | GO:0032366 | |
| GeneOntologyBiologicalProcess | neurotransmitter-gated ion channel clustering | 2.92e-04 | 22 | 309 | 4 | GO:0072578 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC24A5 KLHL24 PRSS8 CNNM2 CACNA2D2 INPP5K TRPC1 CFTR CDH23 RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 PCSK9 ANK3 NSF CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 EGF KCNT2 SLC15A4 SLC22A4 SLC17A8 HTT | 3.03e-04 | 1157 | 309 | 33 | GO:0006812 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 RELN MYCBP2 TSC2 ANKRD27 NEO1 NRXN1 MFN2 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 STXBP5 LAMA5 CPNE5 CIT ACTR2 ZNF335 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 3.14e-04 | 826 | 309 | 26 | GO:0048858 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC24A5 KLHL24 PRSS8 CNNM2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 PCSK9 ANK3 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 HTT | 3.30e-04 | 922 | 309 | 28 | GO:0098662 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | ABCC3 ABCA1 ABCA2 CFTR OSBPL5 MFN2 VPS51 PCSK9 HNF1A TOR1A APOB LDLR EGF LRP1 SLC26A6 | 3.54e-04 | 358 | 309 | 15 | GO:0015850 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 3.70e-04 | 10 | 309 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB6 RELN MYCBP2 TSC2 NEO1 NRXN1 CNTN2 SEMA6C ARHGEF28 LHX4 FN1 ANK3 STXBP5 LAMA5 LRP1 CDH1 CDH2 CDH4 CDH11 LGI1 | 3.72e-04 | 566 | 309 | 20 | GO:0007409 |
| GeneOntologyBiologicalProcess | retina homeostasis | 3.89e-04 | 64 | 309 | 6 | GO:0001895 | |
| GeneOntologyBiologicalProcess | axon guidance | EPHB6 RELN MYCBP2 NEO1 NRXN1 CNTN2 SEMA6C LHX4 ANK3 LAMA5 LRP1 CDH4 LGI1 | 3.92e-04 | 285 | 309 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | RELN MYCBP2 TSC2 ANKRD27 NEO1 NRXN1 NTM MFN2 CNTN2 SEMA6C FN1 FAT3 DDR2 GRID2 CIT ACTR2 CRMP1 LRP1 CDH1 CDH2 CDH4 | 3.93e-04 | 612 | 309 | 21 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB6 RELN MYCBP2 NEO1 NRXN1 CNTN2 SEMA6C LHX4 ANK3 LAMA5 LRP1 CDH4 LGI1 | 4.05e-04 | 286 | 309 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | protein localization to membrane | RELN CACNA2D2 INPP5K BBS2 TSC2 CACNG3 CACNG2 FZD9 NRXN1 SSH1 SNX27 TMEM126A TCAF2 ANK3 GIT1 NSF LAMA5 PIKFYVE LRP1 LRP5 CDH1 CDH2 LGI1 | 4.26e-04 | 705 | 309 | 23 | GO:0072657 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | GABRG1 ABCC3 CFTR ABCC10 TCAF2 SLC26A5 SLC17A8 SLC26A11 SLC26A6 GABRA1 | 4.55e-04 | 183 | 309 | 10 | GO:0006820 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | NAT2 SLC25A26 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 | 4.56e-04 | 120 | 309 | 8 | GO:0003333 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC24A5 KLHL24 PRSS8 CNNM2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 AHNAK SCN2A SCN3A UTRN CNGA4 PCSK9 ANK3 CACHD1 SLC47A2 SLC25A22 SLC6A9 SLC6A12 KCNT2 SLC15A4 SLC17A8 HTT | 4.63e-04 | 942 | 309 | 28 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 4.87e-04 | 25 | 309 | 4 | GO:2000311 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 4.99e-04 | 93 | 309 | 7 | GO:0099068 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 5.03e-04 | 11 | 309 | 3 | GO:0097119 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 5.03e-04 | 11 | 309 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 5.03e-04 | 11 | 309 | 3 | GO:0090118 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 5.40e-04 | 68 | 309 | 6 | GO:0007528 | |
| GeneOntologyBiologicalProcess | learning or memory | RELN ITPR3 FZD9 NLGN4X NRXN1 SCN2A HRH2 DDHD2 CNTN2 GIT1 NLGN4Y LDLR CHRD HTT DNAH11 | 5.43e-04 | 373 | 309 | 15 | GO:0007611 |
| GeneOntologyBiologicalProcess | response to metal ion | CPNE8 TRPC1 ADGRV1 RYR1 RYR2 ITPR3 CACNG2 NRXN1 PCDH15 FN1 ANK3 SLC26A5 CPNE5 CYP2R1 CDH1 HTT | 5.66e-04 | 415 | 309 | 16 | GO:0010038 |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 5.68e-04 | 124 | 309 | 8 | GO:0001704 | |
| GeneOntologyBiologicalProcess | oxalate transport | 6.63e-04 | 12 | 309 | 3 | GO:0019532 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 6.64e-04 | 3 | 309 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor catabolic process | 6.64e-04 | 3 | 309 | 2 | GO:0032805 | |
| GeneOntologyBiologicalProcess | uracil metabolic process | 6.64e-04 | 3 | 309 | 2 | GO:0019860 | |
| GeneOntologyBiologicalProcess | cognition | RELN ITPR3 FZD9 NLGN4X NRXN1 SCN2A HRH2 JAKMIP1 DDHD2 CNTN2 GIT1 NLGN4Y LDLR CHRD HTT DNAH11 | 6.94e-04 | 423 | 309 | 16 | GO:0050890 |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | SLC24A5 RELN ABCA1 ABCA2 TRPC1 CFTR SHPK OSBPL5 RFT1 ALDH3A2 PCSK9 HNF1A CYP27C1 POU1F1 APOB CUBN LDLR CYP2R1 LRP1 LRP5 HTT | 7.14e-04 | 641 | 309 | 21 | GO:1901615 |
| GeneOntologyBiologicalProcess | amino acid transport | NAT2 SLC25A26 APBA1 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 LRP5 | 7.46e-04 | 195 | 309 | 10 | GO:0006865 |
| GeneOntologyBiologicalProcess | lipoprotein transport | 7.62e-04 | 28 | 309 | 4 | GO:0042953 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 7.76e-04 | 130 | 309 | 8 | GO:1905477 | |
| GeneOntologyBiologicalProcess | import into cell | ABCA1 ABCA2 SIGLEC8 MAPKAPK2 TSC2 NOD2 CACNG3 CACNG2 NLGN4X RHOBTB1 FER1L5 CNTN2 PCSK9 ANK3 SLC27A6 NSF NLGN4Y TOR1A CUBN CBLB LDLR PIKFYVE SLC6A9 SLC6A12 EGF SLC15A4 SLC22A4 LRP1 SLC17A8 LRP5 | 8.01e-04 | 1074 | 309 | 30 | GO:0098657 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 8.12e-04 | 49 | 309 | 5 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 8.12e-04 | 49 | 309 | 5 | GO:0099633 | |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC3 ERBB3 ABCA1 CNNM2 EPPK1 TRPC1 CFTR ITGA9 SLC22A7 NOD2 ABCC10 ANK3 SLC26A5 LDLR SLC6A9 SLC6A12 SLC22A4 LRP1 SLC26A11 CDH1 CDH2 SLC26A6 | 2.03e-08 | 354 | 312 | 22 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | ABCC3 ERBB3 ABCA1 CNNM2 EPPK1 TRPC1 CFTR ITGA9 SLC22A7 NOD2 ABCC10 ANK3 SLC26A5 LDLR SLC6A9 SLC6A12 SLC22A4 LRP1 SLC26A11 CDH1 CDH2 SLC26A6 | 6.48e-08 | 378 | 312 | 22 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC3 ERBB3 ABCA1 CNNM2 EPPK1 TRPC1 CFTR SLC22A7 NOD2 ABCC10 ANK3 SLC26A5 LDLR SLC6A9 SLC6A12 LRP1 SLC26A11 CDH1 CDH2 SLC26A6 | 8.25e-08 | 320 | 312 | 20 | GO:0016323 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB6 GABRG1 KLHL24 RELN FRMPD4 CFTR TSC2 ITPR3 CACNG3 CACNG2 GDPD5 NEO1 NLGN4X NRXN1 SCN3A HRH2 SGCE CNGA4 CNTN2 ANK3 GIT1 NSF GLRX3 NLGN4Y FAT3 APBA1 GRID2 APOB CPNE5 SEZ6L2 CIT LDLR CRMP1 EIF5AL1 CST3 EIF5A LRP1 SLC17A8 IL6ST HTT GABRA1 LGI1 KLHL17 | 1.71e-07 | 1228 | 312 | 43 | GO:0036477 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | CDH23 RYR1 RYR2 PHB1 NOD2 PCSK9 STXBP5 CUBN CDH1 CDH2 CDH4 CDH11 | 1.04e-06 | 137 | 312 | 12 | GO:0019897 |
| GeneOntologyCellularComponent | excitatory synapse | CACNG3 NLGN4X NRXN1 NTM CBLN3 GIT1 NLGN4Y GRID2 SLC6A9 SLC17A8 | 4.65e-06 | 107 | 312 | 10 | GO:0060076 |
| GeneOntologyCellularComponent | sarcolemma | POPDC2 RYR1 RYR2 AHNAK SCN2A SGCE FER1L5 UTRN COL6A3 ANK3 SLC27A6 CDH2 SNTB1 | 5.95e-06 | 190 | 312 | 13 | GO:0042383 |
| GeneOntologyCellularComponent | plasma membrane protein complex | ERBB3 ABCA2 CACNA2D2 CDH23 ACVR1 ITGA9 RYR1 CACNG3 CACNG2 NEO1 AHNAK SCN2A SCN3A SGCE UTRN STXBP5 ITGA10 NOX4 GRID2 CACHD1 LRP1 LRP5 CD79B CDH1 CDH2 CDH4 CDH11 SNTB1 IL6ST | 7.41e-06 | 785 | 312 | 29 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | GABRG1 ERBB3 CACNA2D2 PHB1 CACNG3 CACNG2 NEO1 SEPTIN3 NLGN4X NRXN1 SCN2A UTRN CNTN2 ANK3 NLGN4Y STXBP5 PCDHB8 APBA1 GRID2 SLC6A9 LRP1 CDH2 HTT GABRA1 | 8.07e-06 | 583 | 312 | 24 | GO:0097060 |
| GeneOntologyCellularComponent | membrane protein complex | GABRG1 ERBB3 ABCA2 CACNA2D2 TRPC1 CFTR CDH23 ACVR1 ITGA9 RYR1 RYR2 PHB1 CACNG3 CACNG2 NEO1 AHNAK SCN2A SYNE2 SCN3A SNX27 SGCE UTRN CNGA4 DERL1 COPB1 COPG1 STXBP5 ITGA10 NOX4 GRID2 CACHD1 PDIA3 LRP1 SLC17A8 LRP5 CD79B CDH1 CDH2 CDH4 CDH11 SNTB1 SLC26A6 IL6ST GABRA1 | 1.26e-05 | 1498 | 312 | 44 | GO:0098796 |
| GeneOntologyCellularComponent | apical part of cell | ERBB3 CFTR CDH23 ACVR1 SLC22A7 ITPR3 FAT1 PKHD1 GP2 FN1 DDR2 NOX4 CUBN PDIA3 LDLR SLC47A2 SLC6A9 SLC22A4 LRP1 SLC26A11 CDH1 CDH2 SLC26A6 | 3.11e-05 | 592 | 312 | 23 | GO:0045177 |
| GeneOntologyCellularComponent | dendrite | EPHB6 GABRG1 RELN FRMPD4 CFTR TSC2 ITPR3 CACNG3 NLGN4X HRH2 SGCE ANK3 GIT1 NSF GLRX3 NLGN4Y FAT3 APBA1 GRID2 CRMP1 EIF5AL1 EIF5A LRP1 SLC17A8 IL6ST HTT GABRA1 LGI1 KLHL17 | 3.83e-05 | 858 | 312 | 29 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB6 GABRG1 RELN FRMPD4 CFTR TSC2 ITPR3 CACNG3 NLGN4X HRH2 SGCE ANK3 GIT1 NSF GLRX3 NLGN4Y FAT3 APBA1 GRID2 CRMP1 EIF5AL1 EIF5A LRP1 SLC17A8 IL6ST HTT GABRA1 LGI1 KLHL17 | 3.99e-05 | 860 | 312 | 29 | GO:0097447 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRG1 CACNA2D2 TRPC1 CFTR RYR1 RYR2 CACNG3 CACNG2 SCN2A SCN3A CNGA4 STXBP5 GRID2 CACHD1 SLC17A8 SLC26A6 GABRA1 | 5.90e-05 | 378 | 312 | 17 | GO:0034702 |
| GeneOntologyCellularComponent | cell surface | EPHB6 ABCA1 PRSS8 SIGLEC8 CFTR ADGRV1 ITGA9 PHB1 NOD2 CACNG2 FZD9 NEO1 NLGN4X NRXN1 NTM PKHD1 CNTN2 PCSK9 GP2 SEMA6C ANK3 NLGN4Y ITGA10 CUBN PDIA3 LDLR CD226 TLN1 LRP1 CHRD CD79B CDH1 CDH2 IL6ST | 6.01e-05 | 1111 | 312 | 34 | GO:0009986 |
| GeneOntologyCellularComponent | glutamatergic synapse | CNNM2 FRMPD4 TSC2 PHB1 CACNG3 CACNG2 FZD9 NEO1 NLGN4X NRXN1 SCN2A SNX27 GIT1 NLGN4Y APBA1 LAMA5 GRID2 CBLB EEF2 LRP1 SLC17A8 CDH1 CDH2 CDH11 HTT LGI1 KLHL17 | 1.04e-04 | 817 | 312 | 27 | GO:0098978 |
| GeneOntologyCellularComponent | catenin complex | 1.04e-04 | 32 | 312 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.10e-04 | 7 | 312 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | postsynapse | GABRG1 ERBB3 FRMPD4 PSMC5 TSC2 PHB1 CACNG3 CACNG2 FZD9 NEO1 NLGN4X SNX27 UTRN CNTN2 ANK3 GIT1 NSF NLGN4Y PCDHB8 APBA1 GRID2 CBLB ACTR2 CRMP1 SLC6A9 LRP1 CDH1 CDH2 HTT GABRA1 KLHL17 | 1.41e-04 | 1018 | 312 | 31 | GO:0098794 |
| GeneOntologyCellularComponent | extrinsic component of membrane | CDH23 RYR1 RYR2 PHB1 NOD2 PCSK9 STXBP5 CUBN CDH1 CDH2 CDH4 CDH11 | 1.87e-04 | 230 | 312 | 12 | GO:0019898 |
| GeneOntologyCellularComponent | node of Ranvier | 1.95e-04 | 20 | 312 | 4 | GO:0033268 | |
| GeneOntologyCellularComponent | PCSK9-LDLR complex | 2.22e-04 | 2 | 312 | 2 | GO:1990666 | |
| GeneOntologyCellularComponent | costamere | 2.88e-04 | 22 | 312 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.15e-04 | 114 | 312 | 8 | GO:0016528 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.49e-04 | 88 | 312 | 7 | GO:0016529 | |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB3 CFTR SLC22A7 ITPR3 FAT1 PKHD1 GP2 FN1 DDR2 NOX4 CUBN PDIA3 SLC47A2 SLC6A9 SLC22A4 SLC26A11 CDH2 SLC26A6 | 4.12e-04 | 487 | 312 | 18 | GO:0016324 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRG1 ERBB3 CACNG3 CACNG2 NEO1 NLGN4X UTRN CNTN2 ANK3 NLGN4Y PCDHB8 GRID2 SLC6A9 LRP1 CDH2 GABRA1 | 4.18e-04 | 405 | 312 | 16 | GO:0045211 |
| GeneOntologyCellularComponent | receptor complex | GABRG1 ERBB3 TRPC1 ACVR1 ADGRV1 ITGA9 ITPR3 CACNG3 CACNG2 STXBP5 DDR2 ITGA10 GRID2 CUBN LDLR LRP1 LRP5 CD79B IL6ST GABRA1 | 4.95e-04 | 581 | 312 | 20 | GO:0043235 |
| GeneOntologyCellularComponent | late endosome lumen | 4.97e-04 | 11 | 312 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 5.96e-04 | 46 | 312 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | transporter complex | GABRG1 ABCA2 ATP8B4 CACNA2D2 TRPC1 CFTR RYR1 RYR2 CACNG3 CACNG2 SCN2A SCN3A CNGA4 STXBP5 GRID2 CACHD1 SLC17A8 SLC26A6 GABRA1 | 6.53e-04 | 550 | 312 | 19 | GO:1990351 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 KLHL24 EPPK1 FAT1 NRXN1 ARHGAP31 AHNAK SCN2A SYNE2 TLN2 IQGAP3 ANK3 GIT1 DDR2 NOX4 PTPRU PDIA3 ACTR2 PIKFYVE LSR HMCN1 TLN1 LRP1 CDH1 CDH2 CDH4 CDH11 SNTB1 | 7.59e-04 | 976 | 312 | 28 | GO:0070161 |
| GeneOntologyCellularComponent | calcium channel complex | 7.75e-04 | 73 | 312 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | axon initial segment | 8.61e-04 | 29 | 312 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | FRMPD4 TSC2 PHB1 CACNG3 CACNG2 NEO1 NLGN4X NRXN1 ANK3 GIT1 NSF NLGN4Y STXBP5 GRID2 SLC6A9 LRP1 CDH2 KLHL17 | 9.40e-04 | 523 | 312 | 18 | GO:0098984 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG1 ABCA2 CACNA2D2 TRPC1 CFTR RYR1 RYR2 CACNG3 CACNG2 SCN2A SCN3A CNGA4 STXBP5 GRID2 CACHD1 SLC17A8 SLC26A6 GABRA1 | 9.40e-04 | 523 | 312 | 18 | GO:1902495 |
| GeneOntologyCellularComponent | actin-based cell projection | CFTR BBS2 CDH23 ADGRV1 FZD9 FAT1 SYNE2 PCDH15 UTRN CUBN PKHD1L1 CDH1 | 1.02e-03 | 278 | 312 | 12 | GO:0098858 |
| GeneOntologyCellularComponent | cell-substrate junction | EPPK1 FAT1 ARHGAP31 AHNAK SYNE2 TLN2 GIT1 DDR2 NOX4 PDIA3 ACTR2 HMCN1 TLN1 LRP1 CDH2 SNTB1 | 1.09e-03 | 443 | 312 | 16 | GO:0030055 |
| GeneOntologyCellularComponent | inhibitory synapse | 1.11e-03 | 31 | 312 | 4 | GO:0060077 | |
| GeneOntologyCellularComponent | T-tubule | 1.17e-03 | 79 | 312 | 6 | GO:0030315 | |
| GeneOntologyCellularComponent | stereocilium bundle | 1.17e-03 | 79 | 312 | 6 | GO:0032421 | |
| GeneOntologyCellularComponent | lysosome | ABCA2 CFTR TSC2 ANKRD27 PLEKHM1 AHNAK USP4 ABCC10 PCSK9 ANK3 NSF APOB NHLRC3 CUBN CTSA LDLR ACTR2 ARSG EGF SLC15A4 SYNGR1 LRP1 FUCA1 SLC26A11 | 1.19e-03 | 811 | 312 | 24 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ABCA2 CFTR TSC2 ANKRD27 PLEKHM1 AHNAK USP4 ABCC10 PCSK9 ANK3 NSF APOB NHLRC3 CUBN CTSA LDLR ACTR2 ARSG EGF SLC15A4 SYNGR1 LRP1 FUCA1 SLC26A11 | 1.19e-03 | 811 | 312 | 24 | GO:0000323 |
| GeneOntologyCellularComponent | vacuole | ABCA2 CFTR TSC2 ANKRD27 PLEKHM1 AHNAK USP4 ABCC10 PCSK9 ANK3 NSF APOB NHLRC3 CUBN CTSA CIT LDLR ACTR2 ARSG EGF SLC15A4 SYNGR1 LRP1 FUCA1 SLC26A11 HTT | 1.30e-03 | 913 | 312 | 26 | GO:0005773 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.31e-03 | 4 | 312 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | extrinsic component of external side of plasma membrane | 1.31e-03 | 4 | 312 | 2 | GO:0031232 | |
| GeneOntologyCellularComponent | postsynaptic density | FRMPD4 TSC2 PHB1 CACNG3 CACNG2 NEO1 NLGN4X ANK3 GIT1 NSF NLGN4Y GRID2 SLC6A9 LRP1 CDH2 KLHL17 | 1.31e-03 | 451 | 312 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | synaptic cleft | 1.42e-03 | 33 | 312 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.47e-03 | 112 | 312 | 7 | GO:0031594 | |
| GeneOntologyCellularComponent | cell leading edge | GABRG1 INPP5K ADGRV1 FAT1 SSH1 ARHGAP31 SYNE2 TLN2 SGCE GIT1 DOCK8 CIT ACTR2 TLN1 CDH1 CDH2 GABRA1 | 1.47e-03 | 500 | 312 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 KLHL24 EPPK1 FAT1 NRXN1 AHNAK SCN2A TLN2 IQGAP3 ANK3 PTPRU PIKFYVE LSR HMCN1 TLN1 CDH1 CDH2 CDH4 CDH11 | 1.51e-03 | 591 | 312 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization | FRMPD4 TSC2 PHB1 CACNG3 CACNG2 NEO1 NLGN4X ANK3 GIT1 NSF NLGN4Y GRID2 SLC6A9 LRP1 CDH2 GABRA1 KLHL17 | 1.57e-03 | 503 | 312 | 17 | GO:0099572 |
| GeneOntologyCellularComponent | chloride channel complex | 1.59e-03 | 57 | 312 | 5 | GO:0034707 | |
| GeneOntologyCellularComponent | low-density lipoprotein particle | 1.60e-03 | 16 | 312 | 3 | GO:0034362 | |
| GeneOntologyCellularComponent | cell body | KLHL24 RELN CFTR TSC2 ITPR3 GDPD5 NEO1 NRXN1 SCN3A CNGA4 CNTN2 APOB CPNE5 SEZ6L2 CIT CRMP1 PITPNM1 EIF5AL1 CST3 EIF5A LRP1 SLC17A8 PACRG IL6ST HTT KLHL17 | 1.65e-03 | 929 | 312 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | lysosomal membrane | ABCA2 CFTR TSC2 PLEKHM1 AHNAK ABCC10 PCSK9 NSF CUBN CTSA LDLR EGF SLC15A4 SYNGR1 LRP1 SLC26A11 | 1.67e-03 | 462 | 312 | 16 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | ABCA2 CFTR TSC2 PLEKHM1 AHNAK ABCC10 PCSK9 NSF CUBN CTSA LDLR EGF SLC15A4 SYNGR1 LRP1 SLC26A11 | 1.67e-03 | 462 | 312 | 16 | GO:0098852 |
| GeneOntologyCellularComponent | neuronal cell body | KLHL24 RELN CFTR TSC2 ITPR3 GDPD5 NEO1 NRXN1 SCN3A CNGA4 CNTN2 APOB CPNE5 SEZ6L2 CIT CRMP1 EIF5AL1 CST3 EIF5A LRP1 SLC17A8 IL6ST HTT KLHL17 | 1.75e-03 | 835 | 312 | 24 | GO:0043025 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MKKS BBS2 CDH23 ADGRV1 ITPR3 PCDH15 RALGDS CUBN PKHD1L1 SLC26A6 | 1.99e-03 | 223 | 312 | 10 | GO:0098862 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCA2 ATP8B4 CFTR ANKRD27 PLEKHM1 ITPR3 CACNG3 CACNG2 RHOBTB1 SNX27 FER1L5 CNGA4 PCSK9 GP2 APPBP2 COPB1 COPG1 STXBP5 TOR1A APOB CUBN PDIA3 LDLR PIKFYVE SLC6A9 EGF SLC15A4 SYNGR1 LRP1 SLC17A8 SLC26A6 HTT GABRA1 | 2.23e-03 | 1307 | 312 | 33 | GO:0030659 |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.30e-03 | 90 | 312 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | asymmetric synapse | FRMPD4 TSC2 PHB1 CACNG3 CACNG2 NEO1 NLGN4X ANK3 GIT1 NSF NLGN4Y GRID2 SLC6A9 LRP1 CDH2 KLHL17 | 2.30e-03 | 477 | 312 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.33e-03 | 155 | 312 | 8 | GO:0098685 | |
| GeneOntologyCellularComponent | vesicle membrane | ABCA2 ATP8B4 CFTR ANKRD27 PLEKHM1 ITPR3 CACNG3 CACNG2 RHOBTB1 SNX27 FER1L5 CNGA4 PCSK9 GP2 APPBP2 COPB1 COPG1 STXBP5 TOR1A APOB CUBN PDIA3 LDLR PIKFYVE SLC6A9 EGF SLC15A4 SYNGR1 LRP1 SLC17A8 SLC26A6 HTT GABRA1 | 2.76e-03 | 1325 | 312 | 33 | GO:0012506 |
| GeneOntologyCellularComponent | non-motile cilium | 2.81e-03 | 196 | 312 | 9 | GO:0097730 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA2D2 TRPC1 RYR1 RYR2 CACNG3 CACNG2 SCN2A SCN3A CNGA4 CACHD1 | 2.91e-03 | 235 | 312 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | endolysosome membrane | 3.11e-03 | 20 | 312 | 3 | GO:0036020 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 3.11e-03 | 20 | 312 | 3 | GO:0016010 | |
| GeneOntologyCellularComponent | coated vesicle | CFTR DDHD2 PCSK9 COPB1 COPG1 TMED5 APOB CUBN LDLR EGF LRP1 SLC17A8 HTT | 3.11e-03 | 360 | 312 | 13 | GO:0030135 |
| GeneOntologyCellularComponent | membrane raft | ABCA1 PRSS8 TRPC1 TSC2 AHNAK GP2 CBLB LDLR PIKFYVE CD226 CDH1 CDH2 IL6ST | 3.26e-03 | 362 | 312 | 13 | GO:0045121 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.33e-03 | 201 | 312 | 9 | GO:0099634 | |
| GeneOntologyCellularComponent | membrane microdomain | ABCA1 PRSS8 TRPC1 TSC2 AHNAK GP2 CBLB LDLR PIKFYVE CD226 CDH1 CDH2 IL6ST | 3.42e-03 | 364 | 312 | 13 | GO:0098857 |
| GeneOntologyCellularComponent | filopodium membrane | 3.59e-03 | 21 | 312 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | stereocilium | 3.70e-03 | 69 | 312 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | endosome lumen | 3.80e-03 | 43 | 312 | 4 | GO:0031904 | |
| GeneOntologyCellularComponent | axon | KLHL24 RELN MYCBP2 TSC2 CACNG2 BLVRB GDPD5 NEO1 NRXN1 SSH1 NTM SCN2A SCN3A CNTN2 ANK3 GIT1 TOR1A CRMP1 CST3 LRP1 SLC17A8 CDH1 HTT LGI1 | 4.01e-03 | 891 | 312 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | vacuolar membrane | ABCA2 CFTR TSC2 PLEKHM1 AHNAK ABCC10 PCSK9 NSF CUBN CTSA LDLR EGF SLC15A4 SYNGR1 LRP1 SLC26A11 | 4.17e-03 | 507 | 312 | 16 | GO:0005774 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.71e-03 | 212 | 312 | 9 | GO:0030666 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 4.85e-03 | 46 | 312 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | endosome | ABCA1 ABCA2 CFTR PGA5 ANKRD27 PLEKHM1 PHB1 SAMD9L RHOBTB1 SNX27 VPS51 PGA3 PCSK9 GP2 PGA4 DERL1 GIT1 APOB CUBN PDIA3 LDLR PIKFYVE SLC6A9 SLC15A4 CST3 LRP1 SLC17A8 CDH1 HTT | 5.09e-03 | 1167 | 312 | 29 | GO:0005768 |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 5.28e-03 | 24 | 312 | 3 | GO:0032806 | |
| GeneOntologyCellularComponent | secretory granule | ATP8B4 PSMD12 ITPR3 MMP8 TRIM36 GP2 FN1 COPB1 STXBP5 TOR1A NHLRC3 STK31 CTSA PDIA3 ACTR2 PIKFYVE MMRN1 SLC6A9 EEF2 EGF SLC15A4 CDK13 SYNGR1 CST3 LRP1 FUCA1 | 5.29e-03 | 1014 | 312 | 26 | GO:0030141 |
| GeneOntologyCellularComponent | endocytic vesicle | ABCA1 CFTR NOD2 CACNG3 CACNG2 NRXN1 APOB CUBN PDIA3 LDLR PIKFYVE EGF LRP1 | 5.33e-03 | 384 | 312 | 13 | GO:0030139 |
| GeneOntologyCellularComponent | cell projection membrane | GABRG1 INPP5K BBS2 ADGRV1 FZD9 SYNE2 SGCE UTRN CNGA4 DOCK8 CUBN TLN1 SLC26A6 GABRA1 | 5.59e-03 | 431 | 312 | 14 | GO:0031253 |
| GeneOntologyCellularComponent | focal adhesion | FAT1 ARHGAP31 AHNAK SYNE2 TLN2 GIT1 DDR2 NOX4 PDIA3 ACTR2 TLN1 LRP1 CDH2 SNTB1 | 5.59e-03 | 431 | 312 | 14 | GO:0005925 |
| GeneOntologyCellularComponent | B-WICH complex | 5.86e-03 | 8 | 312 | 2 | GO:0110016 | |
| GeneOntologyCellularComponent | glycoprotein complex | 5.94e-03 | 25 | 312 | 3 | GO:0090665 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 6.23e-03 | 78 | 312 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | RELN EMILIN3 FREM2 ADAMTS20 MMP8 COL6A3 FN1 ADAMTS4 COL6A6 LAMA4 LAMA5 MMRN1 HMCN1 CST3 FIBCD1 CDH2 | 6.32e-03 | 530 | 312 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | late endosome | PGA5 ANKRD27 PLEKHM1 PGA3 PCSK9 PGA4 DERL1 LDLR PIKFYVE CST3 SLC17A8 HTT | 6.34e-03 | 348 | 312 | 12 | GO:0005770 |
| GeneOntologyCellularComponent | cell division site | 6.93e-03 | 80 | 312 | 5 | GO:0032153 | |
| MousePheno | abnormal cerebellar layer morphology | RELN ERBB3 HIVEP2 CACNA2D2 CMYA5 SGCE HSD17B4 TMEM176B ANK3 ADAMTS4 TOR1A POU1F1 GRID2 CIT ARSG FUCA1 LGI1 | 1.01e-05 | 263 | 263 | 17 | MP:0009956 |
| MousePheno | abnormal cerebellum morphology | RELN ERBB3 HIVEP2 CACNA2D2 CMYA5 SGCE JAKMIP1 HSD17B4 TMEM176B ANK3 ADAMTS4 TOR1A POU1F1 GRID2 CIT ARSG PIKFYVE FUCA1 HTT LGI1 | 4.80e-05 | 389 | 263 | 20 | MP:0000849 |
| MousePheno | abnormal cerebellar cortex morphology | RELN ERBB3 HIVEP2 CACNA2D2 CMYA5 SGCE HSD17B4 TMEM176B ANK3 ADAMTS4 TOR1A POU1F1 GRID2 CIT ARSG FUCA1 LGI1 | 5.45e-05 | 300 | 263 | 17 | MP:0004097 |
| MousePheno | abnormal orientation of outer hair cell stereociliary bundles | 7.20e-05 | 24 | 263 | 5 | MP:0004491 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | RELN ERBB3 CACNA2D2 CMYA5 SGCE HSD17B4 TMEM176B ANK3 ADAMTS4 TOR1A GRID2 CIT ARSG FUCA1 | 7.32e-05 | 220 | 263 | 14 | MP:0000875 |
| MousePheno | impaired balance | 9.48e-05 | 121 | 263 | 10 | MP:0001525 | |
| MousePheno | abnormal somatic nervous system morphology | MKKS RELN ERBB3 ERCC6 MYCBP2 CACNA2D2 MAPKAPK2 GDF6 PEX1 BBS2 CDH23 ADGRV1 PLEKHM1 CACNG2 NEO1 SYNE2 PCDH15 DHX35 ECEL1 UTRN CNTN2 LRRN1 FAT3 SLC26A5 LAMA4 POU1F1 CACHD1 LDLR ARSG PIKFYVE HMCN1 BARHL1 CST3 CHRD SLC17A8 LRP5 RPGR | 9.54e-05 | 1025 | 263 | 37 | MP:0002752 |
| MousePheno | absent distortion product otoacoustic emissions | 1.08e-04 | 41 | 263 | 6 | MP:0004737 | |
| MousePheno | muscle spasm | 1.27e-04 | 60 | 263 | 7 | MP:0000743 | |
| MousePheno | abnormal metencephalon morphology | RELN ERBB3 HIVEP2 CACNA2D2 CMYA5 SGCE JAKMIP1 HSD17B4 TMEM176B ANK3 ADAMTS4 TOR1A POU1F1 GRID2 CIT ARSG PIKFYVE FUCA1 HTT LGI1 | 1.37e-04 | 420 | 263 | 20 | MP:0000847 |
| MousePheno | neuron degeneration | RELN ERBB3 ERCC6 CACNA2D2 PEX1 CDH23 ADGRV1 PCDH15 HSD17B4 ANK3 SLC26A5 POU1F1 GRID2 ARSG BARHL1 LRP5 FUCA1 RPGR HTT | 1.56e-04 | 391 | 263 | 19 | MP:0003224 |
| MousePheno | abnormal ear position | 1.56e-04 | 28 | 263 | 5 | MP:0000023 | |
| MousePheno | abnormal brain wave pattern | 1.92e-04 | 64 | 263 | 7 | MP:0004994 | |
| MousePheno | muscle twitch | 1.92e-04 | 64 | 263 | 7 | MP:0009046 | |
| MousePheno | abnormal distortion product otoacoustic emission | 1.94e-04 | 85 | 263 | 8 | MP:0004736 | |
| MousePheno | abnormal otoacoustic response | 2.11e-04 | 86 | 263 | 8 | MP:0006336 | |
| MousePheno | neurodegeneration | RELN ERBB3 ERCC6 CACNA2D2 PEX1 CDH23 ADGRV1 PCDH15 HSD17B4 ANK3 SLC26A5 TOR1A POU1F1 GRID2 ARSG BARHL1 LRP5 FUCA1 RPGR HTT LGI1 | 2.12e-04 | 468 | 263 | 21 | MP:0002229 |
| MousePheno | abnormal inner hair cell kinocilium morphology | 2.18e-04 | 7 | 263 | 3 | MP:0011061 | |
| Domain | CA | DCHS2 CDH23 FREM2 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 6.53e-08 | 115 | 312 | 13 | SM00112 |
| Domain | Cadherin | DCHS2 CDH23 FREM2 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 8.89e-08 | 118 | 312 | 13 | IPR002126 |
| Domain | Cadherin_CS | DCHS2 CDH23 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 2.82e-07 | 109 | 312 | 12 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDH23 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 4.19e-07 | 113 | 312 | 12 | PS00232 |
| Domain | Cadherin | DCHS2 CDH23 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 4.19e-07 | 113 | 312 | 12 | PF00028 |
| Domain | - | DCHS2 CDH23 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 4.62e-07 | 114 | 312 | 12 | 2.60.40.60 |
| Domain | CADHERIN_2 | DCHS2 CDH23 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 4.62e-07 | 114 | 312 | 12 | PS50268 |
| Domain | Cadherin-like | DCHS2 CDH23 FAT1 PCDH15 PCDHGB3 FAT3 PCDHB11 PCDHB8 CDH1 CDH2 CDH4 CDH11 | 5.58e-07 | 116 | 312 | 12 | IPR015919 |
| Domain | JAKMIP | 4.62e-06 | 3 | 312 | 3 | IPR024836 | |
| Domain | JAKMIP_C | 4.62e-06 | 3 | 312 | 3 | IPR031994 | |
| Domain | JAKMIP_CC3 | 4.62e-06 | 3 | 312 | 3 | PF16034 | |
| Domain | ConA-like_dom | ADGRV1 CMYA5 ADGRG4 RYR1 RYR2 FAT1 NRXN1 TRIM36 ADGRD1 FAT3 LAMA4 LAMA5 PTPRU MMRN1 | 2.00e-05 | 219 | 312 | 14 | IPR013320 |
| Domain | EGF_1 | RELN FAT1 NRXN1 GP2 FN1 FAT3 LAMA4 LAMA5 CUBN LDLR MMRN1 EGF HMCN1 LRP1 LRP5 | 2.71e-05 | 255 | 312 | 15 | PS00022 |
| Domain | AAA+_ATPase | ABCC3 ABCA1 ABCA2 CFTR PEX1 PSMC5 ABCA9 ABCC10 NSF MMAA DNAH11 | 3.09e-05 | 144 | 312 | 11 | IPR003593 |
| Domain | AAA | ABCC3 ABCA1 ABCA2 CFTR PEX1 PSMC5 ABCA9 ABCC10 NSF MMAA DNAH11 | 3.09e-05 | 144 | 312 | 11 | SM00382 |
| Domain | EGF-like_CS | RELN FAT1 NRXN1 GP2 FN1 FAT3 LAMA4 LAMA5 CUBN LDLR MMRN1 EGF HMCN1 LRP1 LRP5 | 3.54e-05 | 261 | 312 | 15 | IPR013032 |
| Domain | - | ABCC3 ABCA1 ABCA2 SAMD9 ERCC6 CFTR PEX1 PSMC5 ABCA9 NOD2 SAMD9L SEPTIN3 RHOBTB1 MFN2 DHX35 DDX60L ABCC10 NDST1 SMARCA5 NWD1 NSF DHX37 NDST2 TOR1A MMAA EEF2 RASL11B DNAH11 | 5.89e-05 | 746 | 312 | 28 | 3.40.50.300 |
| Domain | Ldl_recept_b | 6.70e-05 | 14 | 312 | 4 | PF00058 | |
| Domain | LDLRB | 6.70e-05 | 14 | 312 | 4 | PS51120 | |
| Domain | VWFA | 6.76e-05 | 82 | 312 | 8 | PS50234 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.17e-05 | 106 | 312 | 9 | IPR000152 | |
| Domain | VWA | 8.04e-05 | 84 | 312 | 8 | SM00327 | |
| Domain | EGF-like_dom | RELN FAT1 NRXN1 GP2 FAT3 LAMA4 LAMA5 CUBN LDLR MMRN1 EGF HMCN1 LRP1 LRP5 | 8.15e-05 | 249 | 312 | 14 | IPR000742 |
| Domain | Ryanodine_recept-rel | 8.90e-05 | 6 | 312 | 3 | IPR015925 | |
| Domain | - | 8.90e-05 | 6 | 312 | 3 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 8.90e-05 | 6 | 312 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.90e-05 | 6 | 312 | 3 | PF08709 | |
| Domain | RIH_assoc | 8.90e-05 | 6 | 312 | 3 | PF08454 | |
| Domain | RIH_dom | 8.90e-05 | 6 | 312 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.90e-05 | 6 | 312 | 3 | IPR014821 | |
| Domain | RYDR_ITPR | 8.90e-05 | 6 | 312 | 3 | PF01365 | |
| Domain | LY | 9.02e-05 | 15 | 312 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 9.02e-05 | 15 | 312 | 4 | IPR000033 | |
| Domain | ABC_TRANSPORTER_2 | 1.41e-04 | 48 | 312 | 6 | PS50893 | |
| Domain | ABC_tran | 1.41e-04 | 48 | 312 | 6 | PF00005 | |
| Domain | Aspartic_peptidase_N | 1.54e-04 | 7 | 312 | 3 | IPR012848 | |
| Domain | S04_transporter_CS | 1.54e-04 | 7 | 312 | 3 | IPR018045 | |
| Domain | Cadherin_pro | 1.54e-04 | 7 | 312 | 3 | PF08758 | |
| Domain | A1_Propeptide | 1.54e-04 | 7 | 312 | 3 | PF07966 | |
| Domain | ABC_TRANSPORTER_1 | 1.58e-04 | 49 | 312 | 6 | PS00211 | |
| Domain | EGF | RELN FAT1 NRXN1 FAT3 LAMA4 LAMA5 CUBN LDLR MMRN1 EGF HMCN1 LRP1 LRP5 | 1.71e-04 | 235 | 312 | 13 | SM00181 |
| Domain | ABC_transporter-like | 1.77e-04 | 50 | 312 | 6 | IPR003439 | |
| Domain | - | 1.91e-04 | 95 | 312 | 8 | 2.60.120.200 | |
| Domain | EGF-like_Ca-bd_dom | 2.39e-04 | 124 | 312 | 9 | IPR001881 | |
| Domain | Cadherin_pro | 2.43e-04 | 8 | 312 | 3 | SM01055 | |
| Domain | Cadherin_pro_dom | 2.43e-04 | 8 | 312 | 3 | IPR014868 | |
| Domain | EGF_CA | 2.54e-04 | 99 | 312 | 8 | PS01187 | |
| Domain | VWF_A | 2.54e-04 | 99 | 312 | 8 | IPR002035 | |
| Domain | ASX_HYDROXYL | 2.72e-04 | 100 | 312 | 8 | PS00010 | |
| Domain | - | 2.78e-04 | 2 | 312 | 2 | 1.20.1420.10 | |
| Domain | VBS | 2.78e-04 | 2 | 312 | 2 | PF08913 | |
| Domain | Talin_cent | 2.78e-04 | 2 | 312 | 2 | IPR015224 | |
| Domain | Talin_middle | 2.78e-04 | 2 | 312 | 2 | PF09141 | |
| Domain | Vinculin-bd_dom | 2.78e-04 | 2 | 312 | 2 | IPR015009 | |
| Domain | NLGN4 | 2.78e-04 | 2 | 312 | 2 | IPR030025 | |
| Domain | LAM_G_DOMAIN | 4.02e-04 | 38 | 312 | 5 | PS50025 | |
| Domain | - | 4.55e-04 | 39 | 312 | 5 | 2.120.10.30 | |
| Domain | P-loop_NTPase | ABCC3 ABCA1 ABCA2 SAMD9 ERCC6 CFTR PEX1 PSMC5 ABCA9 NOD2 SAMD9L SEPTIN3 RHOBTB1 MFN2 DHX35 DDX60L ABCC10 NDST1 SMARCA5 NWD1 NSF DHX37 NDST2 TOR1A MMAA EEF2 RASL11B DNAH11 | 4.87e-04 | 848 | 312 | 28 | IPR027417 |
| Domain | MIR | 5.08e-04 | 10 | 312 | 3 | PF02815 | |
| Domain | Aspartic_peptidase_A1 | 5.08e-04 | 10 | 312 | 3 | IPR001461 | |
| Domain | MIR_motif | 5.08e-04 | 10 | 312 | 3 | IPR016093 | |
| Domain | SLC26A | 5.08e-04 | 10 | 312 | 3 | PS01130 | |
| Domain | MIR | 5.08e-04 | 10 | 312 | 3 | PS50919 | |
| Domain | MIR | 5.08e-04 | 10 | 312 | 3 | SM00472 | |
| Domain | PEPTIDASE_A1 | 5.08e-04 | 10 | 312 | 3 | PS51767 | |
| Domain | PEPTIDASE_A1 | 5.08e-04 | 10 | 312 | 3 | IPR033121 | |
| Domain | Asp | 5.08e-04 | 10 | 312 | 3 | PF00026 | |
| Domain | Laminin_G_2 | 5.13e-04 | 40 | 312 | 5 | PF02210 | |
| Domain | EGF_2 | RELN FAT1 NRXN1 GP2 FAT3 LAMA5 CUBN LDLR MMRN1 EGF HMCN1 LRP1 LRP5 | 5.44e-04 | 265 | 312 | 13 | PS01186 |
| Domain | EGF_CA | 5.90e-04 | 86 | 312 | 7 | PF07645 | |
| Domain | EGF_3 | RELN FAT1 NRXN1 GP2 FAT3 CUBN LDLR MMRN1 EGF HMCN1 LRP1 LRP5 | 6.20e-04 | 235 | 312 | 12 | PS50026 |
| Domain | ABC_transporter_CS | 6.46e-04 | 42 | 312 | 5 | IPR017871 | |
| Domain | SLC26A/SulP_fam | 6.90e-04 | 11 | 312 | 3 | IPR001902 | |
| Domain | STAS_dom | 6.90e-04 | 11 | 312 | 3 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 6.90e-04 | 11 | 312 | 3 | IPR011547 | |
| Domain | STAS | 6.90e-04 | 11 | 312 | 3 | PS50801 | |
| Domain | STAS | 6.90e-04 | 11 | 312 | 3 | PF01740 | |
| Domain | - | 6.90e-04 | 11 | 312 | 3 | 3.30.750.24 | |
| Domain | Sulfate_transp | 6.90e-04 | 11 | 312 | 3 | PF00916 | |
| Domain | BTB-kelch_protein | 7.21e-04 | 43 | 312 | 5 | IPR017096 | |
| Domain | Cadherin_C | 7.32e-04 | 25 | 312 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 7.32e-04 | 25 | 312 | 4 | IPR000233 | |
| Domain | LamG | 8.02e-04 | 44 | 312 | 5 | SM00282 | |
| Domain | IF5A_HYPUSINE | 8.25e-04 | 3 | 312 | 2 | PS00302 | |
| Domain | Transl_elong_IF5A_C | 8.25e-04 | 3 | 312 | 2 | IPR020189 | |
| Domain | Transl_elong_IF5A | 8.25e-04 | 3 | 312 | 2 | IPR001884 | |
| Domain | Ser_caboxypep_ser_AS | 8.25e-04 | 3 | 312 | 2 | IPR018202 | |
| Domain | RyR | 8.25e-04 | 3 | 312 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 8.25e-04 | 3 | 312 | 2 | PF06459 | |
| Domain | eIF-5a | 8.25e-04 | 3 | 312 | 2 | SM01376 | |
| Domain | CARBOXYPEPT_SER_SER | 8.25e-04 | 3 | 312 | 2 | PS00131 | |
| Domain | Ryan_recept | 8.25e-04 | 3 | 312 | 2 | IPR013333 | |
| Domain | CARBOXYPEPT_SER_HIS | 8.25e-04 | 3 | 312 | 2 | PS00560 | |
| Domain | Peptidase_S10 | 8.25e-04 | 3 | 312 | 2 | PF00450 | |
| Domain | eIF-5a | 8.25e-04 | 3 | 312 | 2 | PF01287 | |
| Domain | Ryanodine_rcpt | 8.25e-04 | 3 | 312 | 2 | IPR003032 | |
| Domain | Talin-1 | 8.25e-04 | 3 | 312 | 2 | IPR015710 | |
| Domain | Peptidase_S10 | 8.25e-04 | 3 | 312 | 2 | IPR001563 | |
| Domain | CDC48_domain_2-like | 8.25e-04 | 3 | 312 | 2 | IPR029067 | |
| Domain | Ryanrecept_TM4-6 | 8.25e-04 | 3 | 312 | 2 | IPR009460 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 ABCC3 ABCA1 ABCA2 ATP8B4 TRPC1 CFTR PSMC5 PSMD12 SLC25A26 ABCA9 SLC22A7 RYR1 RYR2 PHB1 SLC35D1 ABCC10 PCSK9 CUL1 DERL1 SLC27A6 GLRX3 APOB CUBN LDLR SLC47A2 SLC25A22 SLC6A9 SLC6A12 LSR SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 6.11e-08 | 736 | 246 | 35 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 ABCC3 ABCA1 ABCA2 ATP8B4 TRPC1 CFTR PSMC5 PSMD12 SLC25A26 ABCA9 SLC22A7 RYR1 RYR2 PHB1 SLC35D1 ABCC10 PCSK9 CUL1 DERL1 SLC27A6 APOB LDLR SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 9.62e-07 | 681 | 246 | 31 | MM14985 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.07e-04 | 84 | 246 | 8 | M7098 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.08e-04 | 44 | 246 | 6 | M11911 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC25A26 SLC22A7 SLC35D1 SLC27A6 SLC47A2 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 1.23e-04 | 249 | 246 | 14 | M5988 |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2 | 1.40e-04 | 16 | 246 | 4 | M42564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.55e-04 | 30 | 246 | 5 | M47724 | |
| Pathway | WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES | 1.80e-04 | 17 | 246 | 4 | M39747 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB6 RELN TRPC1 PSMC5 PSMD12 ADGRV1 ITGA9 NEO1 SCN2A SCN3A UTRN CNTN2 CUL2 COL6A3 ARHGEF28 LHX4 ANK3 COL6A6 GIT1 ITGA10 ACTR2 CRMP1 TLN1 | 1.87e-04 | 575 | 246 | 23 | M29853 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRG1 TSC2 CACNG3 CACNG2 TYMS NLGN4X NRXN1 ALDH1L2 SCN2A SCN3A CNTN2 NOX4 CUBN MMAA ATIC MMUT GABRA1 | 2.50e-04 | 367 | 246 | 17 | M48346 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC25A26 SLC22A7 SLC35D1 SLC27A6 SLC25A22 SLC6A9 SLC6A12 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 2.85e-04 | 238 | 246 | 13 | MM15076 |
| Pathway | REACTOME_LDL_CLEARANCE | 2.85e-04 | 19 | 246 | 4 | M27846 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.01e-04 | 74 | 246 | 7 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.01e-04 | 74 | 246 | 7 | M39462 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.35e-04 | 99 | 246 | 8 | MM14986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 4.29e-04 | 21 | 246 | 4 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 4.29e-04 | 21 | 246 | 4 | M47949 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 4.29e-04 | 37 | 246 | 5 | M27847 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 4.38e-04 | 103 | 246 | 8 | M758 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 ABCA2 EPPK1 HIVEP2 MYCBP2 MAPKAPK2 FBXL12 IPP TSC2 KDM6B ZNF236 PLEKHM1 RYR1 ITPR3 NOD2 GDPD5 FAT1 SSH1 XPO6 AHNAK OSBPL5 MFN2 TLN2 IQGAP3 CRAMP1 ABCC10 SEMA6C NDST1 POLE LAMA5 SPATA20 CFAP43 CIT LDLR ARSG PIKFYVE SLC25A22 CDK13 ZNF335 TLN1 LRP5 HTT KLHL17 | 1.56e-15 | 1105 | 319 | 43 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 ABCA2 MYCBP2 TSC2 FAT1 XPO6 SGCE ECEL1 RFT1 ALDH3A2 USP15 SLC27A3 PCSK9 NDST1 GLRX3 TMED5 TOR1A LAMA4 DNAJC18 LAMA5 CACHD1 CTSA SEZ6L2 PDIA3 LDLR EEF2 CST3 LRP1 TMPO LRP5 SCPEP1 TMEM131 CDH2 IL6ST HTT | 2.07e-09 | 1201 | 319 | 35 | 35696571 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MKKS KNTC1 SF3B4 EPPK1 MYCBP2 INPP5K PSMC5 TSC2 PSMD12 CMYA5 XPO6 MMS19 APOBEC3C USF1 USP15 CUL2 CUL1 HNF1A GIT1 COPG1 NSF GLRX3 DHX37 POLE TOR1A PAAF1 CTSA PRPF40A ACTR2 SLC25A22 LSR IGF2BP2 RHPN2 PRPF3 BARHL1 ATIC | 3.30e-09 | 1284 | 319 | 36 | 17353931 |
| Pubmed | EPHB6 DCHS2 RELN ERBB3 ABCA2 SF3B4 HIVEP2 MYCBP2 IFT172 TSC2 CMYA5 KDM6B SEPTIN3 TLN2 DHX35 JAKMIP1 HSD17B4 UTRN TARBP1 NDST1 FN1 ANK3 COPB1 GIT1 APBA1 CACHD1 JAKMIP3 CPNE5 CIT CRMP1 EEF2 CTR9 LRP1 TMEM131 ATIC LGI1 | 3.37e-09 | 1285 | 319 | 36 | 35914814 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SF3B4 EPPK1 PSMC5 PSMD12 CHEK1 XPO6 AHNAK TLN2 VPS51 GOLGB1 CUL1 SMARCA5 COPB1 COPG1 NSF DOCK8 POLE SMCHD1 PRPF40A ACTR2 PRPF3 TLN1 TMPO | 6.04e-09 | 582 | 319 | 23 | 20467437 |
| Pubmed | SECISBP2L MKKS MYCBP2 FBXL12 PEX1 TSC2 ANKRD27 ECEL1 VPS51 GMPPB IQGAP3 TMEM126A SMARCA5 COPB1 NSF POLE ATG2B ACTR2 DHRS7B SLC25A22 VPS13D TMPO TMEM131 | 1.28e-08 | 606 | 319 | 23 | 36538041 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PEX1 PSMC5 TSC2 PGM3 PHB1 ITPR3 XPO6 MMS19 RFT1 ALDH3A2 VPS51 COG5 ANAPC5 IQGAP3 TARBP1 SLC27A3 DERL1 COPB1 COPG1 NSF POLE DNAJC18 CACHD1 DHRS7B SLC25A22 LSR TLN1 TMPO ATIC | 1.67e-08 | 942 | 319 | 29 | 31073040 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CNNM2 IFT172 FBXL12 PSMC5 PSMD12 CHEK1 PGM3 ITPR3 TYMS CSNK1A1L SSH1 SNX27 ALDH3A2 UTRN SLC27A3 CUL2 COPG1 NSF POLE SMCHD1 PTPRU PAAF1 PDIA3 LSR IGF2BP2 CTR9 EIF5A LRP1 SNTB1 | 3.42e-08 | 974 | 319 | 29 | 28675297 |
| Pubmed | 1.02e-07 | 86 | 319 | 9 | 26885983 | ||
| Pubmed | 2.26e-07 | 29 | 319 | 6 | 20167577 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L MYCBP2 IFT172 BBS2 CDH23 PSMC5 TSC2 PSMD12 CHEK1 PGM3 PHB1 EML5 NRXN1 XPO6 AHNAK SNX27 RFT1 VPS51 USP15 IQGAP3 CUL2 ANK3 GIT1 NSF GLRX3 ATG2B CTSA PDIA3 PRPF3 CTR9 FUCA1 RPGR PACRG | 2.27e-07 | 1321 | 319 | 33 | 27173435 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYCBP2 FBXL12 PSMC5 TSC2 PSMD12 PGM3 PHB1 TYMS MFN2 MMS19 HSD17B4 ALDH3A2 GMPPB USP15 IQGAP3 CUL2 CUL1 TMEM126A COPB1 COPG1 RNASEH2A NSF DHX37 POLE ACTR2 DHRS7B SLC25A22 EEF2 CTR9 EIF5A TMPO HSD17B11 | 2.32e-07 | 1257 | 319 | 32 | 37317656 |
| Pubmed | Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. | 2.38e-07 | 7 | 319 | 4 | 23676495 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PRSS8 GALM PSMC5 PSMD12 ADGRV1 RYR1 BLVRB FAT1 EML5 AHNAK PKHD1 UTRN COL6A3 FN1 LAMA5 CUBN CPNE5 CTSA ACTR2 EEF2 VPS13D EGF TLN1 CST3 SCPEP1 FUCA1 ATIC SLC26A11 | 2.88e-07 | 1016 | 319 | 28 | 19056867 |
| Pubmed | ZSCAN12 MYCBP2 TSC2 JAKMIP2 CACNG2 CSNK1A1L SEPTIN3 NRXN1 SSH1 SYNE2 MFN2 TLN2 JAKMIP1 GOLGB1 ANK3 GIT1 NSF MSANTD2 SPATA20 JAKMIP3 CIT CRMP1 EEF2 LRP1 CDH2 CDH11 LGI1 | 3.39e-07 | 963 | 319 | 27 | 28671696 | |
| Pubmed | EPHB6 ERBB3 ACVR1 SSH1 USP4 ECEL1 MMP8 USP15 PGA3 CUL2 CUL1 ADAMTS4 TOR1A PTPRU CPNE5 PDIA3 LDLR HARS2 CDK13 LRP1 KDM1B DNAH11 KLHL17 | 3.58e-07 | 730 | 319 | 23 | 34857952 | |
| Pubmed | 4.72e-07 | 8 | 319 | 4 | 7750641 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SF3B4 EPPK1 PSMC5 PSMD12 PHB1 BLVRB NTM AHNAK SYNE2 A2ML1 HSD17B4 COG5 GMPPB UTRN GOLGB1 CUL2 SMARCA5 COPB1 COPG1 NSF CTSA PDIA3 PRPF40A EEF2 IGF2BP2 TLN1 CST3 EIF5A LRP1 TMPO ATIC HSD17B11 MMUT | 4.89e-07 | 1367 | 319 | 33 | 32687490 |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 23846497 | ||
| Pubmed | Identification and characterization of two novel (neuro)endocrine long coiled-coil proteins. | 7.64e-07 | 3 | 319 | 3 | 17572408 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 7926498 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 9561228 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 21455714 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 19800305 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 19319977 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 7.64e-07 | 3 | 319 | 3 | 1968039 | |
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 7.64e-07 | 3 | 319 | 3 | 2566575 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 20538126 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 7.64e-07 | 3 | 319 | 3 | 19890696 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 23675525 | ||
| Pubmed | The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia. | 7.64e-07 | 3 | 319 | 3 | 33418990 | |
| Pubmed | Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia. | 7.64e-07 | 3 | 319 | 3 | 17539906 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 6774973 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 6300126 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 24004680 | ||
| Pubmed | A systematic review of LDLR, PCSK9, and APOB variants in Asia. | 7.64e-07 | 3 | 319 | 3 | 32629184 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 23034090 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 7.64e-07 | 3 | 319 | 3 | 3554488 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 23521833 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 3017318 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 9855083 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 34756585 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 2478370 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 7.64e-07 | 3 | 319 | 3 | 10675278 | |
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 7.64e-07 | 3 | 319 | 3 | 3839486 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 25839937 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 3467902 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 7.64e-07 | 3 | 319 | 3 | 2892778 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 24383519 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 7.64e-07 | 3 | 319 | 3 | 2831884 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 20145306 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 30844855 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 1812762 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 7923573 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 16159606 | ||
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 7.64e-07 | 3 | 319 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 7.64e-07 | 3 | 319 | 3 | 1956484 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 22992016 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 7.64e-07 | 3 | 319 | 3 | 8504820 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 20428942 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 9525001 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 29261184 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 7886402 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 21547904 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 20236128 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 23593297 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 7.64e-07 | 3 | 319 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 7.64e-07 | 3 | 319 | 3 | 2799289 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 19872561 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 17142622 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 8053437 | ||
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 7.64e-07 | 3 | 319 | 3 | 2229438 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 25314140 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 34403115 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 7.64e-07 | 3 | 319 | 3 | 8244094 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 21407214 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 7.64e-07 | 3 | 319 | 3 | 22304859 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 7.64e-07 | 3 | 319 | 3 | 2227273 | |
| Pubmed | The genetic spectrum of familial hypercholesterolemia in the central south region of China. | 7.64e-07 | 3 | 319 | 3 | 28235710 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 24125879 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 37853441 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 8751234 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 7.64e-07 | 3 | 319 | 3 | 21989121 | |
| Pubmed | Editorial: designing targeted sequencing panels for dyslipidemia. | 7.64e-07 | 3 | 319 | 3 | 30664017 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 9797498 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 3780036 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 2901984 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 2032552 | ||
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 9061458 | ||
| Pubmed | Genetic heterogeneity of autosomal dominant hypercholesterolemia. | 7.64e-07 | 3 | 319 | 3 | 18028451 | |
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 7.64e-07 | 3 | 319 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 7.64e-07 | 3 | 319 | 3 | 23897256 | |
| Pubmed | 7.64e-07 | 3 | 319 | 3 | 8540382 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 7.64e-07 | 3 | 319 | 3 | 20981206 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 7.64e-07 | 3 | 319 | 3 | 21970995 | |
| Interaction | TOP3B interactions | ABCC3 ABCA2 EPPK1 HIVEP2 MYCBP2 MAPKAPK2 FBXL12 IPP TSC2 KDM6B ZNF236 PLEKHM1 RYR1 PHB1 ITPR3 NOD2 GDPD5 FAT1 SSH1 XPO6 AHNAK OSBPL5 MFN2 TLN2 MMS19 IQGAP3 CRAMP1 ABCC10 SEMA6C CUL2 NDST1 GLRX3 POLE APBA1 LAMA5 SPATA20 APOB CFAP43 CIT LDLR ACTR2 ARSG PIKFYVE SLC25A22 IGF2BP2 CDK13 ZNF335 TLN1 LRP5 HTT KLHL17 | 6.72e-08 | 1470 | 316 | 51 | int:TOP3B |
| Interaction | TAFAZZIN interactions | CACNA2D2 CFTR ADGRV1 FREM2 FAT1 USP15 PCSK9 CUL1 NDST1 NDST2 NHLRC3 SLC22A4 LRP5 TMEM131 | 5.24e-06 | 207 | 316 | 14 | int:TAFAZZIN |
| Interaction | PTCH1 interactions | ABCA2 CACNA2D2 PSMC5 PSMD12 PHB1 CSNK1A1L USP15 PCSK9 CUL2 CUL1 APPBP2 NDST2 LAMA5 PIKFYVE CHRD TMEM131 | 7.08e-06 | 273 | 316 | 16 | int:PTCH1 |
| Interaction | RHOJ interactions | CPNE8 ACVR1 PHB1 FAT1 NEO1 SGCE MMS19 VPS51 UTRN IQGAP3 CUL1 TMEM126A DERL1 GIT1 NSF DOCK8 DHX37 CACHD1 DHRS7B LSR TMPO LRP5 CDH2 SNTB1 SLC26A6 IL6ST | 8.36e-06 | 633 | 316 | 26 | int:RHOJ |
| Interaction | NXPH2 interactions | 1.10e-05 | 33 | 316 | 6 | int:NXPH2 | |
| Interaction | RHOA interactions | CPNE8 EPPK1 TRPC1 CFTR PHB1 ITPR3 FAT1 ARHGAP31 SYNE2 ALDH3A2 VPS51 UTRN IQGAP3 GOLGB1 TMEM126A ARHGEF28 ANK3 DERL1 NSF DHX37 STXBP5 CTSA CIT CRMP1 DHRS7B PITPNM1 SLC6A9 LSR VPS13D RHPN2 SLC22A4 TMPO LRP5 RPGR CDH1 SLC26A6 IL6ST HTT KLHL17 | 1.28e-05 | 1199 | 316 | 39 | int:RHOA |
| GeneFamily | Cadherin related | 1.78e-06 | 17 | 231 | 5 | 24 | |
| GeneFamily | Solute carriers | SLC24A5 SLC25A26 SLC22A7 SLC35D1 SLC27A3 SLC27A6 SLC26A5 SLC47A2 SLC25A22 SLC6A9 SLC6A12 SLC25A36 SLC15A4 SLC22A4 SLC17A8 SLC26A11 SLC26A6 | 1.38e-05 | 395 | 231 | 17 | 752 |
| GeneFamily | CD molecules|Type I classical cadherins | 2.02e-05 | 5 | 231 | 3 | 1185 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.84e-04 | 3 | 231 | 2 | 287 | |
| GeneFamily | Low density lipoprotein receptors | 5.36e-04 | 13 | 231 | 3 | 634 | |
| GeneFamily | ATP binding cassette subfamily C | 5.36e-04 | 13 | 231 | 3 | 807 | |
| GeneFamily | ATP binding cassette subfamily A | 6.75e-04 | 14 | 231 | 3 | 805 | |
| GeneFamily | Fibronectin type III domain containing | 1.06e-03 | 160 | 231 | 8 | 555 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.69e-03 | 134 | 231 | 7 | 861 | |
| GeneFamily | Kelch like|BTB domain containing | 1.99e-03 | 42 | 231 | 4 | 617 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 2.31e-03 | 21 | 231 | 3 | 980 | |
| GeneFamily | EMI domain containing | 3.27e-03 | 7 | 231 | 2 | 540 | |
| GeneFamily | PDZ domain containing | 3.43e-03 | 152 | 231 | 7 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.31e-03 | 26 | 231 | 3 | 253 | |
| GeneFamily | Cullins | 4.33e-03 | 8 | 231 | 2 | 1032 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.66e-03 | 53 | 231 | 4 | 532 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.52e-03 | 9 | 231 | 2 | 1234 | |
| GeneFamily | Copines | 5.52e-03 | 9 | 231 | 2 | 829 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.52e-03 | 9 | 231 | 2 | 1203 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L GABRG1 SYCP2L RELN FRMPD4 MYCBP2 LRRC49 PEX1 TSC2 RYR2 CACNG2 NLGN4X NRXN1 NTM SCN2A SCN3A TLN2 TARBP1 ADGRD1 PDZRN4 RALGDS ANK3 COL6A6 STXBP5 APBA1 LAMA5 NOX4 GRID2 CPNE5 SEZ6L2 CRMP1 SLC25A22 ANKRD44 SLC22A4 CDH4 GABRA1 | 7.73e-08 | 1106 | 317 | 36 | M39071 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | MYCBP2 PSMC5 ACVR1 PHB1 NEO1 AHNAK MFN2 HRH2 ALDH3A2 FN1 COPB1 LAMA5 LDLR EGF CST3 FUCA1 RPGR IL6ST HTT | 2.20e-07 | 379 | 317 | 19 | M1885 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GABRG1 FRMPD4 MYCBP2 RYR2 CACNG2 EML5 NRXN1 NTM SCN2A SCN3A TLN2 JAKMIP1 TRIM36 TARBP1 RALGDS ANK3 STXBP5 GRID2 JAKMIP3 SEZ6L2 DENND3 CRMP1 ANKRD44 CDH4 GABRA1 | 1.78e-06 | 703 | 317 | 25 | M39070 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L HIVEP2 MYCBP2 TRPC1 ACVR1 FAT1 XPO6 SYNE2 COG5 USP15 SLC27A3 CUL2 CUL1 DPYD APPBP2 SMARCA5 SMCHD1 DDR2 TRAPPC8 CBLB LDLR PIKFYVE ZZZ3 CDK13 MAP4K5 TMEM131 RPGR CDH2 | 2.14e-06 | 856 | 317 | 28 | M4500 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | CPNE8 ABCA1 ATP8B4 SAMD9 NOD2 GDPD5 IRF9 SAMD9L ARHGAP31 SNX27 HRH2 DDX60L MMP8 USF1 USP15 UTRN SLC27A3 CUL1 TMEM176B SMCHD1 NHLRC3 LDLR DHRS7B SLC6A12 IGF2BP2 SLC15A4 SLC22A4 CST3 SCPEP1 KDM1B SNTB1 | 2.33e-06 | 1012 | 317 | 31 | M40868 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | FRMPD4 MYCBP2 LRRC49 CACNG2 NTM SCN2A SCN3A JAKMIP1 TRIM36 PDZRN4 SEMA6C RALGDS ANK3 STXBP5 APBA1 SEZ6L2 CRMP1 ANKRD44 CDH4 LGI1 | 5.17e-06 | 513 | 317 | 20 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | RELN FRMPD4 CACNG2 GDPD5 SEPTIN3 NRXN1 SCN2A SCN3A JAKMIP1 TRIM36 PDZRN4 RALGDS ANK3 STXBP5 FAT3 APBA1 JAKMIP3 SEZ6L2 CRMP1 ANKRD44 CDH4 | 1.03e-05 | 584 | 317 | 21 | M39068 |
| Coexpression | CUI_TCF21_TARGETS_2_UP | KNTC1 RELN CFTR PHB1 TYMS SYNE2 ADAMTS20 IQGAP3 TMEM176B FN1 SMCHD1 FAT3 LAMA4 CPNE5 LSR KCNT2 CD79B ATIC | 1.26e-05 | 455 | 317 | 18 | MM1189 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | ABCC3 CPAMD8 ERBB3 EPPK1 TRPC1 BLVRB AHNAK CD101 HRH2 TLN2 HSD17B4 ALDH3A2 SEMA6C COL6A3 DPYD FN1 APBA1 CACHD1 CTSA SLC47A2 MMRN1 LRP1 LRP5 FUCA1 | 1.34e-05 | 740 | 317 | 24 | M41202 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 2.66e-05 | 72 | 317 | 7 | M45791 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | KNTC1 RELN CFTR TYMS SYNE2 ADAMTS20 IQGAP3 TMEM176B FN1 SMCHD1 FAT3 LAMA4 CPNE5 LSR KCNT2 CD79B ATIC | 2.72e-05 | 437 | 317 | 17 | M1610 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP | EPHB6 KLHL24 HIVEP2 IPP ITPR3 FAT1 ABCC10 SLC27A3 CUL2 ZNF335 SLC26A6 | 3.33e-05 | 199 | 317 | 11 | M8028 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | MYCBP2 TSC2 ALDH3A2 USP15 DPYD TRAPPC8 PRPF40A ACTR2 ZZZ3 TMEM131 CDH2 | 3.33e-05 | 199 | 317 | 11 | M5201 |
| Coexpression | GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN | SF3B4 EPPK1 FAT1 ADAMTS20 MMP8 TRIM36 IQGAP3 PDZRN4 FAT3 EXOSC1 ATIC | 3.48e-05 | 200 | 317 | 11 | M6396 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | MKKS KNTC1 GIN1 CHEK1 TYMS SGCE IQGAP3 DERL1 RNASEH2A GLRX3 TMED5 DDR2 CTSA CIT PRPF40A ACTR2 MAP4K5 EIF5A TMPO ATIC IL6ST | 4.33e-05 | 644 | 317 | 21 | M10501 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | RELN LRRC49 CACNG2 SEPTIN3 NLGN4X NRXN1 ALDH1L2 SCN3A JAKMIP1 TRIM36 ANK3 SEZ6L2 CRMP1 ANKRD44 | 6.51e-05 | 335 | 317 | 14 | M39065 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | CHEK1 ACVR1 ADGRV1 TYMS FREM2 FAT1 ARHGEF28 RNASEH2A FAT3 NOX4 MMRN1 RPGR LGI1 | 1.04e-04 | 307 | 317 | 13 | M39058 |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP | GLT8D2 WDR64 FBXL12 CACNG2 NEO1 CRAMP1 CNTN2 CIT KCNT2 SLC26A11 | 1.04e-04 | 188 | 317 | 10 | M3332 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | DNAJC22 CMYA5 ITPR3 FREM2 NEO1 XPO6 HRH2 PDZRN4 RALGDS TMEM176B ANK3 LRRN1 GIT1 LAMA5 GRID2 CACHD1 SEZ6L2 PKHD1L1 LSR KCNT2 RHPN2 SCPEP1 FUCA1 PACRG SLC26A11 CDH2 | 1.11e-04 | 955 | 317 | 26 | M45680 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.17e-04 | 40 | 317 | 5 | M5887 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.24e-04 | 64 | 317 | 6 | M2572 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | EPHB6 CPAMD8 CFTR RYR2 FREM2 CNGA4 LRRN1 LAMA5 GRID2 PTPRU STK31 SEZ6L2 RHPN2 | 1.26e-04 | 313 | 317 | 13 | M40228 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | GABRG1 GLT8D2 FRMPD4 MYCBP2 NRXN1 SCN2A SCN3A JAKMIP1 TARBP1 RALGDS APBA1 CPNE5 SEZ6L2 CRMP1 ANKRD44 LGI1 | 1.33e-04 | 450 | 317 | 16 | M39072 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 8.84e-06 | 10 | 311 | 4 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 ERCC6 GIN1 TRPC1 IPP CHEK1 EML5 SNX27 MAP3K15 DDHD2 NOL8 CUL2 POLE FAM3B TEX14 CUBN TRAPPC8 CPNE5 STK31 PPP4R4 PIKFYVE CYP2R1 RHPN2 PRPF3 RPGR CFAP61 KDM1B CDH1 HTT | 1.18e-05 | 820 | 311 | 29 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN FRMPD4 CFTR ADGRV1 RYR2 FREM2 FAT1 NRXN1 SCN2A PCDH15 PKHD1 ADAMTS20 TLN2 CNTN2 FAT3 APOB PKHD1L1 HMCN1 DNAH11 | 9.43e-17 | 184 | 318 | 19 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN FRMPD4 CFTR ADGRV1 RYR2 FREM2 FAT1 NRXN1 SCN2A PCDH15 PKHD1 ADAMTS20 TLN2 CNTN2 FAT3 APOB PKHD1L1 HMCN1 DNAH11 | 9.43e-17 | 184 | 318 | 19 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN FRMPD4 CFTR ADGRV1 RYR2 FREM2 FAT1 NRXN1 SCN2A PCDH15 PKHD1 ADAMTS20 TLN2 CNTN2 FAT3 APOB PKHD1L1 HMCN1 DNAH11 | 9.43e-17 | 184 | 318 | 19 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GLT8D2 CPAMD8 ABCA9 NLGN4X PDZRN4 COL6A3 FN1 COL6A6 DDR2 ITGA10 GRID2 KCNT2 LRP1 RASL11B CDH11 | 1.78e-11 | 200 | 318 | 15 | a4ec0e80f5422b91b85264a9bb74568dd577e285 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SAMD9 MYCBP2 IRF9 SAMD9L AHNAK SYNE2 DDX60L USP15 UTRN GOLGB1 SMARCA5 DOCK8 SMCHD1 ANKRD44 CDK13 | 1.78e-11 | 200 | 318 | 15 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ABCC3 CMYA5 FAT1 RHOBTB1 SYNE2 PKHD1 ARHGEF28 ANK3 NOX4 CUBN SLC47A2 IGF2BP2 RHPN2 PACRG | 1.42e-10 | 194 | 318 | 14 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 RYR2 NTM HRH2 COL6A3 FN1 COL6A6 DDR2 LAMA4 LRP1 CDH11 IL6ST | 2.19e-09 | 199 | 318 | 13 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 RYR2 PDZRN4 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 KCNT2 HMCN1 LRP1 CDH11 | 2.33e-09 | 200 | 318 | 13 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | GLT8D2 CDH23 ABCA9 ADGRG4 ADGRD1 PDZRN4 COL6A3 DDR2 LAMA4 GRID2 LRP1 CDH11 | 1.19e-08 | 188 | 318 | 12 | ce85a56ac27a6432421dde93a1bafa8b943244b9 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 NTM PCDH15 HRH2 COL6A3 COL6A6 SLC27A6 FAT3 DDR2 LAMA4 LRP1 CDH11 | 1.26e-08 | 189 | 318 | 12 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 RYR2 NTM PCDH15 HRH2 COL6A3 COL6A6 FAT3 DDR2 LAMA4 LRP1 CDH11 | 1.42e-08 | 191 | 318 | 12 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | ABCA9 NLGN4X COL6A3 NLGN4Y DDR2 NOX4 CBLB ANKRD44 KCNT2 CST3 HSD17B11 SNTB1 | 1.42e-08 | 191 | 318 | 12 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 NTM PCDH15 HRH2 COL6A3 COL6A6 FAT3 DDR2 LAMA4 GRID2 LRP1 CDH11 | 1.68e-08 | 194 | 318 | 12 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 NTM PCDH15 COL6A3 COL6A6 SLC27A6 FAT3 DDR2 LAMA4 GRID2 LRP1 CDH11 | 1.68e-08 | 194 | 318 | 12 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCA9 RYR2 PCDH15 TLN2 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 CDH11 | 1.89e-08 | 196 | 318 | 12 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SECISBP2L ADGRV1 SYNE2 PKHD1 ECEL1 UTRN GOLGB1 ANK3 SLC26A5 LDLR LSR CDH1 | 2.00e-08 | 197 | 318 | 12 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.11e-08 | 159 | 318 | 11 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | CDH23 ABCA9 RYR2 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 LRP1 CDH11 | 2.11e-08 | 198 | 318 | 12 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA1 RYR2 NTM PCDH15 HRH2 ADGRD1 COL6A3 COL6A6 DDR2 LDLR LRP1 CDH11 | 2.24e-08 | 199 | 318 | 12 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | ABCA1 MYCBP2 RYR2 NTM HRH2 COL6A3 COL6A6 DDR2 LAMA4 LRP1 CDH11 IL6ST | 2.36e-08 | 200 | 318 | 12 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 RYR2 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 NOX4 HMCN1 LRP1 CDH11 | 2.36e-08 | 200 | 318 | 12 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 LRP1 CDH11 | 2.36e-08 | 200 | 318 | 12 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | SECISBP2L CPAMD8 CFTR ADGRV1 ITGA9 FAT1 SYNE2 SGCE CACHD1 CIT HSD17B11 | 4.21e-08 | 170 | 318 | 11 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DCHS2 RYR2 NRXN1 ADGRD1 NLGN4Y FAT3 DDR2 SLC6A12 LRP1 CDH2 SNTB1 | 4.21e-08 | 170 | 318 | 11 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CDH23 ITGA9 ABCA9 ADGRG4 ADGRD1 COL6A3 DDR2 LAMA4 KCNT2 LRP1 CDH11 | 5.67e-08 | 175 | 318 | 11 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | RELN ERBB3 ABCA9 NLGN4X NRXN1 NTM SGCE TMEM176B ANK3 ANKRD30A CDH2 | 6.75e-08 | 178 | 318 | 11 | 611504b0a9e6318b18fba83787b03f9245c82252 |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | RELN ERBB3 ABCA9 NLGN4X NRXN1 NTM SGCE TMEM176B ANK3 ANKRD30A CDH2 | 6.75e-08 | 178 | 318 | 11 | d9142151819afb0dc22bfb32a9c9dba5f553067d |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBB3 SLC35D1 SHPK PCSK9 DPYD NOX4 LDLR SLC6A12 LSR SLC17A8 CDH2 | 8.46e-08 | 182 | 318 | 11 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBB3 SLC35D1 SHPK PCSK9 DPYD NOX4 LDLR SLC6A12 LSR SLC17A8 CDH2 | 8.46e-08 | 182 | 318 | 11 | 4921c7d5687cc79f896b39753bb621d7e3d2972f |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBB3 SLC35D1 SHPK PCSK9 DPYD NOX4 LDLR SLC6A12 LSR SLC17A8 CDH2 | 8.46e-08 | 182 | 318 | 11 | 770ce9f3f4538d0181a0181543841bc964c68274 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CNNM2 RYR2 FAT1 NRXN1 ADGRD1 ADAMTS4 COL6A6 NLGN4Y APBA1 SLC6A9 KCNT2 | 9.46e-08 | 184 | 318 | 11 | 689a8af81a79a4bb3123cfa01958c953eab5de98 |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | RELN ERBB3 ABCA1 PKHD1 ARHGEF28 SLC6A12 IGF2BP2 LRP1 PACRG CDH1 SNTB1 | 1.00e-07 | 185 | 318 | 11 | 1d874608aa2062024323512f68889219471b2f00 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA9 RYR2 PCDH15 COL6A3 FN1 ADAMTS4 COL6A6 DDR2 LAMA4 HMCN1 CDH11 | 1.06e-07 | 186 | 318 | 11 | 5473283fb95cee556b1f6934cf72169b676b5bcc |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ADGRV1 RYR2 AHNAK SCN2A PKHD1 ADAMTS20 USP15 TLN1 CST3 LRP1 CDH11 | 1.06e-07 | 186 | 318 | 11 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 LAMA4 GRID2 HMCN1 CDH11 | 1.11e-07 | 187 | 318 | 11 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | RELN WDR64 CACNG3 CACNG2 NRXN1 PCDH15 ADAMTS20 GRID2 ANKRD30A CDH4 | 1.16e-07 | 148 | 318 | 10 | d6ac5972267254651dfbe16bb4e9a62228093cc7 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FAT1 NTM SYNE2 PKHD1 FAT3 CFAP43 CRMP1 SLC6A12 CDH2 SNTB1 DNAH11 | 1.24e-07 | 189 | 318 | 11 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CDH23 ABCA9 ADGRG4 ADGRD1 PDZRN4 COL6A3 DDR2 LAMA4 GRID2 LRP1 CDH11 | 1.31e-07 | 190 | 318 | 11 | efb757f11c2809e66ddb48a5c84f5433f111cb7c |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | EPHB6 CACNA2D2 RYR2 SCN2A SCN3A ANK3 FAT3 CPNE5 SEZ6L2 GABRA1 LGI1 | 1.31e-07 | 190 | 318 | 11 | 6e92c78799f34b31d098854503c796edb0dc7f80 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 CDH11 | 1.31e-07 | 190 | 318 | 11 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC22A7 RHOBTB1 SYNE2 PCDH15 PKHD1 TLN2 ANK3 NOX4 CUBN SLC47A2 CDH2 | 1.38e-07 | 191 | 318 | 11 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC22A7 RHOBTB1 SYNE2 PCDH15 PKHD1 TLN2 ANK3 NOX4 CUBN SLC47A2 CDH2 | 1.38e-07 | 191 | 318 | 11 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | RYR2 NTM SCN3A HRH2 UTRN ADGRD1 PDZRN4 COL6A3 FN1 GRID2 CBLB | 1.38e-07 | 191 | 318 | 11 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | SECISBP2L CPAMD8 ERBB3 CFTR ADGRV1 FREM2 PKHD1 ANK3 LAMA5 CACHD1 CDH1 | 1.38e-07 | 191 | 318 | 11 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FRMPD4 NTM PCDH15 HRH2 COL6A3 COL6A6 FAT3 DDR2 GRID2 LRP1 CDH11 | 1.46e-07 | 192 | 318 | 11 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PCDH15 HRH2 COL6A3 ADAMTS4 COL6A6 FAT3 DDR2 LAMA4 LRP1 CDH11 | 1.46e-07 | 192 | 318 | 11 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | CPNE8 ITGA9 PCDH15 FN1 ITGA10 PKHD1L1 MMRN1 KCNT2 HMCN1 CDH11 IL6ST | 1.53e-07 | 193 | 318 | 11 | 01c2df9206f1527c578e808978e58196c35e72f5 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 CDH11 | 1.53e-07 | 193 | 318 | 11 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | ABCA9 NLGN4X PDZRN4 COL6A3 DPYD FN1 DDR2 NOX4 CBLB ANKRD44 KCNT2 | 1.62e-07 | 194 | 318 | 11 | 11c79a8c56ece42713b04b321982e41e239f07a5 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 GRID2 LRP1 CDH11 | 1.62e-07 | 194 | 318 | 11 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | ABCA9 RYR2 COL6A3 FN1 ADAMTS4 COL6A6 DDR2 LAMA4 NOX4 HMCN1 CDH11 | 1.62e-07 | 194 | 318 | 11 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | RYR2 NTM COL6A3 FN1 COL6A6 NLGN4Y FAT3 LAMA4 HMCN1 CDH4 CDH11 | 1.62e-07 | 194 | 318 | 11 | 35f132cc38ac133be01834ed0946188aa0757eb4 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 LAMA4 IGF2BP2 HMCN1 CDH11 | 1.70e-07 | 195 | 318 | 11 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | ERBB3 PRSS8 CACNA2D2 CFTR ITPR3 FREM2 SMARCA5 LAMA5 FAM3B LSR CDH1 | 1.70e-07 | 195 | 318 | 11 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 CDH11 | 1.70e-07 | 195 | 318 | 11 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 LAMA4 HMCN1 LRP1 CDH11 | 1.70e-07 | 195 | 318 | 11 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 CDH11 | 1.70e-07 | 195 | 318 | 11 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 LAMA4 HMCN1 LRP1 CDH11 | 1.70e-07 | 195 | 318 | 11 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA9 RYR2 ADGRD1 PDZRN4 COL6A3 FAT3 DDR2 LAMA4 GRID2 KCNT2 CDH11 | 1.79e-07 | 196 | 318 | 11 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA9 RYR2 ADGRD1 PDZRN4 COL6A3 FAT3 DDR2 LAMA4 GRID2 KCNT2 CDH11 | 1.79e-07 | 196 | 318 | 11 | 1c8294014713684b50885e638668f2ce75f357f0 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 CDH11 | 1.79e-07 | 196 | 318 | 11 | cecf82cd5e0a3835d655f5e7478578674a63ce25 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ABCA1 RYR2 NTM HRH2 COL6A3 COL6A6 DDR2 LAMA4 LRP1 CDH11 IL6ST | 1.89e-07 | 197 | 318 | 11 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ITGA9 ABCA9 ADGRG4 COL6A3 FN1 COL6A6 LAMA4 NOX4 HMCN1 LRP1 CDH11 | 1.89e-07 | 197 | 318 | 11 | 0dd71e399f253787fa546a7e90c5373180b89ffd |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | RYR2 NTM COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 KCNT2 HMCN1 CDH11 | 1.99e-07 | 198 | 318 | 11 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | TRPC1 EMILIN3 ITPR3 ADGRD1 PCSK9 PDZRN4 ARHGEF28 FN1 ITGA10 LRP1 CDH11 | 2.09e-07 | 199 | 318 | 11 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SECISBP2L CACNA2D2 CFTR ADGRV1 ITPR3 FREM2 ADGRD1 PCSK9 ANK3 SEZ6L2 LDLR | 2.09e-07 | 199 | 318 | 11 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | ABCA9 RYR2 COL6A3 TMEM176B FN1 COL6A6 DDR2 LAMA4 HMCN1 LRP1 CDH11 | 2.09e-07 | 199 | 318 | 11 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | IRF9 SYNE2 USP15 UTRN GOLGB1 ANK3 SMCHD1 CBLB ANKRD44 CD226 CDK13 | 2.09e-07 | 199 | 318 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | ABCA9 RYR2 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 KCNT2 HMCN1 CDH11 | 2.09e-07 | 199 | 318 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | ABCA9 RYR2 COL6A3 TMEM176B FN1 COL6A6 DDR2 LAMA4 HMCN1 LRP1 CDH11 | 2.09e-07 | 199 | 318 | 11 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 158 | 318 | 10 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 TLN2 PDZRN4 COL6A3 ADAMTS4 DDR2 LAMA4 NOX4 KCNT2 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 RYR2 COL6A3 FN1 COL6A6 FAT3 DDR2 LAMA4 HMCN1 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPAMD8 ABCA9 ADGRD1 PDZRN4 COL6A3 FN1 DDR2 LAMA4 KCNT2 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 LAMA4 HMCN1 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA1 ABCA9 ADGRD1 PDZRN4 COL6A3 DDR2 LAMA4 NOX4 KCNT2 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SAMD9 CACNA2D2 JAKMIP2 SAMD9L AHNAK SYNE2 JAKMIP1 UTRN SMCHD1 CBLB CD226 | 2.20e-07 | 200 | 318 | 11 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | ERBB3 PRSS8 EPPK1 ITPR3 FAT1 LRRN1 CYP27C1 SEZ6L2 LSR CDH1 CDH2 | 2.20e-07 | 200 | 318 | 11 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 RYR2 PCDH15 COL6A3 FN1 COL6A6 FAT3 LAMA4 HMCN1 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | CNNM2 SPEGNB RYR2 FAT1 ADGRD1 COL6A3 DDR2 LAMA4 SLC6A9 KCNT2 LRP1 | 2.20e-07 | 200 | 318 | 11 | 5ed4261157cd51109b314818133ac3a0d34ee5fa |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CNNM2 SPEGNB RYR2 FAT1 ADGRD1 COL6A3 FN1 DDR2 LAMA4 SLC6A9 KCNT2 | 2.20e-07 | 200 | 318 | 11 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 ADGRG4 ADGRD1 COL6A3 COL6A6 DDR2 LAMA4 KCNT2 HMCN1 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ABCC3 ERBB3 FAT1 RHOBTB1 SYNE2 TMEM176B NOX4 CUBN SEZ6L2 SLC47A2 CDH2 | 2.20e-07 | 200 | 318 | 11 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | CNNM2 RYR2 FAT1 HRH2 ADGRD1 COL6A6 DDR2 SLC6A9 KCNT2 LRP1 CDH2 | 2.20e-07 | 200 | 318 | 11 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | GLT8D2 ABCA9 SGCE ADGRD1 TMEM176B FN1 DDR2 LAMA4 NOX4 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | 7ba292c30d915e66ebc8026fa76492cedf64700e |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 ADGRG4 TLN2 PDZRN4 COL6A3 ADAMTS4 DDR2 LAMA4 NOX4 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | CPAMD8 ABCA1 NTM PCDH15 COL6A3 FN1 COL6A6 DDR2 LAMA4 LRP1 CDH11 | 2.20e-07 | 200 | 318 | 11 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | WDR64 CFTR ADGRV1 RYR2 PKHD1 PDZRN4 FAT3 PKHD1L1 KCNT2 HMCN1 | 2.41e-07 | 160 | 318 | 10 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | WDR64 CFTR ADGRV1 RYR2 PKHD1 PDZRN4 FAT3 PKHD1L1 KCNT2 HMCN1 | 2.41e-07 | 160 | 318 | 10 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.03e-07 | 164 | 318 | 10 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.03e-07 | 164 | 318 | 10 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 3.21e-07 | 165 | 318 | 10 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.39e-07 | 166 | 318 | 10 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-07 | 167 | 318 | 10 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-07 | 168 | 318 | 10 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-07 | 168 | 318 | 10 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | RELN ERBB3 NLGN4X NRXN1 ARHGAP31 NTM AHNAK ANK3 CYP27C1 RPGR | 3.79e-07 | 168 | 318 | 10 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HIVEP2 ADGRV1 RYR2 SCN3A PCDH15 PKHD1 FAT3 CUBN PKHD1L1 DNAH11 | 4.00e-07 | 169 | 318 | 10 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 4.97e-07 | 173 | 318 | 10 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | JAKMIP2 SYNE2 JAKMIP1 UTRN NLRC3 COL6A3 SMCHD1 CBLB ANKRD44 CFAP61 | 5.82e-07 | 176 | 318 | 10 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa |
| Computational | Adhesion molecules. | RELN FAT1 NEO1 COL6A3 FN1 DDR2 APBA1 LAMA4 LAMA5 MMRN1 CDH1 CDH2 | 8.87e-06 | 141 | 194 | 12 | MODULE_122 |
| Drug | ptaquiloside | CHEK1 ADGRV1 FAT1 NEO1 NRXN1 PCDH15 HNF1A FAT3 LAMA4 GRID2 CD226 CDH4 | 3.56e-07 | 133 | 316 | 12 | ctd:C043680 |
| Drug | 5 alpha-cholest-8(14)-en-3 beta-ol-15-one | 2.44e-06 | 8 | 316 | 4 | CID000039756 | |
| Drug | AC1L1EJT | 2.84e-06 | 64 | 316 | 8 | CID000002823 | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | KLHL24 EPPK1 HIVEP2 GDPD5 USP15 GLRX3 PTPRU PITPNM1 SLC25A36 CYP2R1 CDK13 TMPO IL6ST | 3.07e-06 | 192 | 316 | 13 | 2292_DN |
| Drug | gallopamil | 4.04e-06 | 67 | 316 | 8 | CID000001234 | |
| Drug | verapamil | EPHB6 ABCC3 ABCA1 ABCA2 CACNA2D2 CFTR ABCA9 RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN3A VPS51 ABCC10 APOB LDLR EGF KCNT2 MAP4K5 SLC22A4 | 5.65e-06 | 490 | 316 | 21 | CID000002520 |
| Drug | genistein | GABRG1 NAT2 ABCC3 KLHL24 ERBB3 CACNA2D2 MAPKAPK2 CFTR CHEK1 ITGA9 RYR1 RYR2 ITPR3 CACNG2 TYMS IRF9 MMP8 ALDH3A2 ABCC10 COL6A3 FN1 DDR2 ITGA10 LAMA4 LAMA5 APOB PIKFYVE EEF2 CD7 EGF EIF5A TMPO ATIC CDH2 GABRA1 | 6.35e-06 | 1117 | 316 | 35 | CID005280961 |
| Drug | procaine | GABRG1 CACNA2D2 CFTR RYR1 RYR2 ITPR3 CACNG3 CACNG2 SCN3A TUBD1 GABRA1 | 1.00e-05 | 153 | 316 | 11 | CID000004914 |
| Drug | 148504-47-6 | 1.05e-05 | 4 | 316 | 3 | CID006444275 | |
| Drug | Cinildipine | 1.20e-05 | 56 | 316 | 7 | CID000002752 | |
| Drug | pantogab | KLHL24 CPNE8 ABCA1 EPPK1 ACVR1 CHKB SHPK AHNAK SNX27 NOL8 CUL2 FN1 ANK3 DOCK8 TMED5 NOX4 TRAPPC8 CBLB SLC25A22 KCNT2 HSD17B11 CDH1 IL6ST | 1.28e-05 | 601 | 316 | 23 | ctd:C016030 |
| Drug | AC1L98DX | 1.29e-05 | 38 | 316 | 6 | CID000439957 | |
| Drug | ap1-6 | 1.37e-05 | 23 | 316 | 5 | CID003030073 | |
| Drug | beta-alanine | 1.48e-05 | 104 | 316 | 9 | CID000000239 | |
| Drug | N-methyl-DL-aspartic acid | GABRG1 RELN ERBB3 CACNA2D2 INPP5K TRPC1 ADGRV1 RYR1 RYR2 ITPR3 CACNG3 CACNG2 FAT1 NSF APBA1 GRID2 CIT LDLR PIKFYVE SLC6A9 LRP1 CDH2 HTT GABRA1 | 1.69e-05 | 655 | 316 | 24 | CID000004376 |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | EPHB6 ABCC3 ABCA2 HIVEP2 MAPKAPK2 PEX1 SHPK DENND3 PPP4R4 EGF LRP5 MMUT | 1.83e-05 | 194 | 316 | 12 | 1205_UP |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | KLHL24 CHEK1 KDM6B JAKMIP2 COG5 FN1 ANK3 LDLR CRMP1 PIKFYVE SYNGR1 IL6ST | 1.93e-05 | 195 | 316 | 12 | 421_UP |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; PC3; HT_HG-U133A | ABCA2 SIGLEC8 ITPR3 NLGN4X SCN3A HRH2 TLN2 SEMA6C DDR2 LDLR EGF SYNGR1 | 2.03e-05 | 196 | 316 | 12 | 4191_UP |
| Drug | phthalocyaninetetrasulfonic acid | 2.04e-05 | 41 | 316 | 6 | CID005742784 | |
| Drug | Frie Mao 1-43 | 2.13e-05 | 61 | 316 | 7 | CID002733618 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | GLT8D2 CFTR NOD2 SGCE FN1 APBA1 ITGA10 LAMA4 TEX14 EGF RPGR CDH2 | 2.14e-05 | 197 | 316 | 12 | 3867_UP |
| Drug | felodipine | CACNA2D2 CFTR RYR1 RYR2 ITPR3 NOD2 CACNG3 CACNG2 TYMS EGF CYP2R1 | 2.55e-05 | 169 | 316 | 11 | CID000003333 |
| Drug | G11459 | 2.70e-05 | 43 | 316 | 6 | CID000472328 | |
| Drug | lamotrigine | 3.54e-05 | 116 | 316 | 9 | CID000003878 | |
| Drug | Pluronic | 3.64e-05 | 90 | 316 | 8 | CID000024751 | |
| Drug | methylmalonic acid | 4.36e-05 | 68 | 316 | 7 | CID000000487 | |
| Drug | ethylene acrylic acid | 5.14e-05 | 6 | 316 | 3 | CID000062701 | |
| Disease | Colorectal Carcinoma | EPHB6 ABCC3 CPAMD8 ABCA1 ERCC6 CFTR IPP PSMC5 JAKMIP2 ABCA9 TYMS FAT1 CSNK1A1L NLGN4X PKHD1 JAKMIP1 PDZRN4 RALGDS DPYD FN1 POLE GRID2 APOB PTPRU CUBN ZZZ3 RHPN2 CD226 LRP1 CDH1 IL6ST | 3.43e-11 | 702 | 316 | 31 | C0009402 |
| Disease | Ciliopathies | 3.14e-07 | 110 | 316 | 10 | C4277690 | |
| Disease | cortical thickness | CPAMD8 KLHL24 RELN ERBB3 CNNM2 MYCBP2 LRRC49 GDF6 SLC25A26 ADGRV1 PLEKHM1 FZD9 NEO1 PKHD1 ADAMTS20 TRIM36 USP15 ABCC10 PDZRN4 SLC27A6 NSF FAT3 TMED5 PCDHB11 DENND3 CRMP1 VPS13D LRP1 RASL11B TMEM131 CDH11 SNTB1 | 4.64e-07 | 1113 | 316 | 32 | EFO_0004840 |
| Disease | total lipids in lipoprotein particles measurement | 7.64e-07 | 48 | 316 | 7 | EFO_0022309 | |
| Disease | HMG CoA reductase inhibitor use measurement | TDRD15 NAT2 ABCA1 ITPR3 SEPTIN3 PCSK9 HNF1A APOB LDLR IGF2BP2 MAP4K5 DNAH11 | 1.04e-06 | 189 | 316 | 12 | EFO_0009932 |
| Disease | hearing impairment | ERCC6 CACNA2D2 CDH23 ADGRV1 PCDH15 HSD17B4 SLC26A5 SLC17A8 RPGR | 1.13e-06 | 98 | 316 | 9 | C1384666 |
| Disease | Intellectual Disability | HIVEP2 FRMPD4 KDM6B PGM3 NRXN1 SCN3A SNX27 ALDH3A2 NDST1 RALGDS RNASEH2A NSF DOCK8 ZNF335 FUCA1 ATIC CDH2 HTT | 1.90e-06 | 447 | 316 | 18 | C3714756 |
| Disease | Colorectal Neoplasms | ABCC3 CPAMD8 ABCA1 CFTR IPP ABCA9 TYMS FAT1 DPYD POLE RHPN2 CD226 CDH1 IL6ST | 2.02e-06 | 277 | 316 | 14 | C0009404 |
| Disease | triglycerides in LDL measurement | 2.24e-06 | 56 | 316 | 7 | EFO_0022320 | |
| Disease | Disorder of eye | SLC24A5 MKKS BBS2 CDH23 ADGRV1 FREM2 PCDH15 MFN2 TMEM126A PRPF3 LRP5 RPGR | 3.44e-06 | 212 | 316 | 12 | C0015397 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 5.37e-06 | 150 | 316 | 10 | EFO_0004611, EFO_0020947 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | TRPC1 TSC2 ITPR3 NLGN4X NRXN1 SCN2A JAKMIP1 NDST1 NLGN4Y NDST2 | 6.04e-06 | 152 | 316 | 10 | DOID:0060041 (implicated_via_orthology) |
| Disease | triglycerides in large LDL measurement | 6.28e-06 | 43 | 316 | 6 | EFO_0022319 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 7.46e-06 | 26 | 316 | 5 | OBA_2045194 | |
| Disease | saturated fatty acids measurement | 8.24e-06 | 45 | 316 | 6 | EFO_0022304 | |
| Disease | esterified cholesterol measurement | 1.03e-05 | 128 | 316 | 9 | EFO_0008589 | |
| Disease | polyunsaturated fatty acid measurement | 1.25e-05 | 131 | 316 | 9 | EFO_0010733 | |
| Disease | coronary artery disease | TDRD15 NAT2 ABCA1 CNNM2 HIVEP2 CFTR CHKB PHB1 GDPD5 NRXN1 PKHD1 JAKMIP1 COG5 ABCC10 PCSK9 GP2 COL6A3 DPYD HNF1A FN1 SLC27A6 DOCK8 APOB PTPRU LDLR ACTR2 IGF2BP2 ZNF335 SLC22A4 LRP1 | 1.53e-05 | 1194 | 316 | 30 | EFO_0001645 |
| Disease | response to statin, LDL cholesterol change measurement | 1.60e-05 | 15 | 316 | 4 | EFO_0007804, GO_0036273 | |
| Disease | total lipids in LDL measurement | 1.94e-05 | 52 | 316 | 6 | EFO_0022308 | |
| Disease | total phospholipids in lipoprotein particles measurement | 2.16e-05 | 53 | 316 | 6 | EFO_0022315 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.69e-05 | 111 | 316 | 8 | EFO_0004530, EFO_0008595 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | TDRD15 NAT2 FZD9 HSD17B4 PCSK9 HNF1A COPB1 APOB LDLR MAP4K5 DNAH11 | 2.79e-05 | 220 | 316 | 11 | EFO_0004529, EFO_0008317 |
| Disease | cholesterol to total lipids in large LDL percentage | 2.98e-05 | 56 | 316 | 6 | EFO_0022235 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | TDRD15 NAT2 ABCA1 FZD9 SYNE2 HNF1A COPB1 APOB LDLR MAP4K5 ZNF335 | 3.30e-05 | 224 | 316 | 11 | EFO_0004530, EFO_0008317 |
| Disease | total lipids in large LDL | 3.30e-05 | 57 | 316 | 6 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 3.30e-05 | 57 | 316 | 6 | EFO_0021901 | |
| Disease | Hypercholesterolemia, Familial | 3.51e-05 | 18 | 316 | 4 | C0020445 | |
| Disease | triglycerides in IDL measurement | 3.65e-05 | 58 | 316 | 6 | EFO_0022149 | |
| Disease | low density lipoprotein particle size measurement | 3.65e-05 | 58 | 316 | 6 | EFO_0008593 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.65e-05 | 85 | 316 | 7 | EFO_0004639, EFO_0004732 | |
| Disease | LDL cholesterol change measurement | 4.12e-05 | 7 | 316 | 3 | EFO_0007804 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 4.18e-05 | 118 | 316 | 8 | EFO_0010119 | |
| Disease | alkaline phosphatase measurement | TDRD15 NAT2 CNNM2 SAMD9 TSC2 PLEKHM1 FZD9 XPO6 AHNAK PRR14L COG5 UTRN GOLGB1 ABCC10 PDZRN4 RALGDS HNF1A TMEM176B APOB ARSG CRMP1 EIF5AL1 RHPN2 MAP4K5 EIF5A KLHL17 | 4.19e-05 | 1015 | 316 | 26 | EFO_0004533 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.00e-05 | 121 | 316 | 8 | EFO_0008595, EFO_0020943 | |
| Disease | lipid measurement, lipoprotein measurement | 5.28e-05 | 90 | 316 | 7 | EFO_0004529, EFO_0004732 | |
| Disease | triglycerides in medium LDL measurement | 5.34e-05 | 62 | 316 | 6 | EFO_0022322 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | TDRD15 NAT2 ABCA1 PCSK9 HNF1A APOB LDLR MAP4K5 ZNF335 DNAH11 | 5.68e-05 | 197 | 316 | 10 | EFO_0005680 |
| Disease | phosphatidylcholine measurement | TDRD15 SYCP2L ABCA1 IFT172 SYNE2 PGA3 HNF1A APOB LDLR MAP4K5 SLC22A4 CDH2 | 6.30e-05 | 284 | 316 | 12 | EFO_0010226 |
| Disease | Familial hypercholesterolemia | 6.55e-05 | 8 | 316 | 3 | cv:C0020445 | |
| Disease | cholesterol in very small VLDL measurement | 6.60e-05 | 40 | 316 | 5 | EFO_0022231 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 6.98e-05 | 94 | 316 | 7 | EFO_0008595, EFO_0010351 | |
| Disease | epilepsy (implicated_via_orthology) | 7.00e-05 | 163 | 316 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 7.04e-05 | 127 | 316 | 8 | EFO_0008595, EFO_0020947 | |
| Disease | docosahexaenoic acid measurement | 7.04e-05 | 127 | 316 | 8 | EFO_0007761 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | TDRD15 NAT2 ABCA1 SYNE2 PCSK9 HNF1A COPB1 APOB LDLR MMAA MAP4K5 HTT | 7.94e-05 | 291 | 316 | 12 | EFO_0008317, EFO_0020946 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 8.05e-05 | 166 | 316 | 9 | EFO_0004530, EFO_0004611 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 9.41e-05 | 43 | 316 | 5 | EFO_0022290 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 9.70e-05 | 99 | 316 | 7 | EFO_0004611, EFO_0007878 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 9.70e-05 | 99 | 316 | 7 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 9.70e-05 | 99 | 316 | 7 | EFO_0004639, EFO_0008595 | |
| Disease | neuroimaging measurement | SECISBP2L DCHS2 RELN ERBB3 SAMD9 LRRC49 IPP SLC25A26 SLC35D1 FZD9 NEO1 PKHD1 ADAMTS20 TLN2 ANK3 SLC27A6 FAT3 DENND3 CRMP1 RHPN2 PRPF3 RASL11B TUBD1 CDH11 HTT DNAH11 | 9.74e-05 | 1069 | 316 | 26 | EFO_0004346 |
| Disease | USHER SYNDROME, TYPE ID | 1.14e-04 | 2 | 316 | 2 | 601067 | |
| Disease | Familial monosomy 7 syndrome | 1.14e-04 | 2 | 316 | 2 | cv:C5681220 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 1.14e-04 | 2 | 316 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | Poisoning by fluorouracil | 1.14e-04 | 2 | 316 | 2 | C0274576 | |
| Disease | Usher syndrome, type 1D | 1.14e-04 | 2 | 316 | 2 | C2931208 | |
| Disease | hypobetalipoproteinemia (is_implicated_in) | 1.14e-04 | 2 | 316 | 2 | DOID:1390 (is_implicated_in) | |
| Disease | USHER SYNDROME, TYPE ID | 1.14e-04 | 2 | 316 | 2 | C1832845 | |
| Disease | Familial primary hypomagnesemia with normocalciuria and normocalcemia | 1.14e-04 | 2 | 316 | 2 | C4510731 | |
| Disease | Usher syndrome type 1D | 1.14e-04 | 2 | 316 | 2 | cv:C1832845 | |
| Disease | level of bifunctional purine biosynthesis protein ATIC in blood serum | 1.14e-04 | 2 | 316 | 2 | OBA_2040722 | |
| Disease | C-reactive protein measurement | TDRD15 NAT2 DCHS2 ABCA1 IFT172 FZD9 NEO1 NTM AHNAK PCDH15 ANAPC5 SLC27A3 SEMA6C DPYD HNF1A ARHGEF28 ANK3 NDST2 APOB CACHD1 CIT ANKRD44 SLC6A9 MAP4K5 SLC17A8 TUBD1 CDH4 DNAH11 | 1.15e-04 | 1206 | 316 | 28 | EFO_0004458 |
| Disease | Coronary heart disease | 1.16e-04 | 24 | 316 | 4 | C0010068 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.17e-04 | 102 | 316 | 7 | EFO_0004329, EFO_0004611 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.17e-04 | 45 | 316 | 5 | EFO_0022236 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.20e-04 | 137 | 316 | 8 | EFO_0004611, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement | TDRD15 NAT2 ABCA1 HSD17B4 PCSK9 HNF1A COPB1 APOB LDLR MAP4K5 DNAH11 | 1.25e-04 | 260 | 316 | 11 | EFO_0008317 |
| Disease | homocysteine measurement | 1.31e-04 | 46 | 316 | 5 | EFO_0004578 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.38e-04 | 10 | 316 | 3 | DOID:13810 (is_implicated_in) | |
| Disease | phospholipid measurement | 1.39e-04 | 140 | 316 | 8 | EFO_0004639 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | TDRD15 NAT2 ABCA1 SYNE2 PCSK9 APOB LDLR MAP4K5 ZNF335 SNTB1 HTT | 1.43e-04 | 264 | 316 | 11 | EFO_0008317, EFO_0020944 |
| Disease | free cholesterol in very small VLDL measurement | 1.45e-04 | 47 | 316 | 5 | EFO_0022275 | |
| Disease | waist-hip ratio | KNTC1 CPAMD8 ABCA1 MYCBP2 CFTR PSMD12 ACVR1 ITGA9 AHNAK SCN2A SYNE2 ADAMTS20 CNTN2 ABCC10 PDZRN4 NDST1 DPYD APPBP2 FN1 ANK3 COPB1 SMCHD1 LAMA4 IGF2BP2 KCNT2 CD79B SNTB1 HTT | 1.51e-04 | 1226 | 316 | 28 | EFO_0004343 |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.60e-04 | 26 | 316 | 4 | OBA_2045191 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.69e-04 | 144 | 316 | 8 | EFO_0004611, EFO_0020943 | |
| Disease | phospholipids in medium LDL measurement | 1.77e-04 | 49 | 316 | 5 | EFO_0022183 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.77e-04 | 49 | 316 | 5 | EFO_0022256 | |
| Disease | free cholesterol in large LDL measurement | 2.14e-04 | 51 | 316 | 5 | EFO_0022176 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.14e-04 | 51 | 316 | 5 | EFO_0022285 | |
| Disease | free cholesterol measurement | 2.21e-04 | 113 | 316 | 7 | EFO_0008591 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 2.34e-04 | 114 | 316 | 7 | EFO_0004574, EFO_0004611 | |
| Disease | phospholipids in IDL measurement | 2.35e-04 | 52 | 316 | 5 | EFO_0022164 | |
| Disease | antihyperlipidemic drug use measurement | 2.47e-04 | 115 | 316 | 7 | EFO_0803367 | |
| Disease | phospholipids in large LDL measurement | 2.57e-04 | 53 | 316 | 5 | EFO_0022174 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.57e-04 | 53 | 316 | 5 | EFO_0022340 | |
| Disease | triglycerides in HDL measurement | 2.57e-04 | 53 | 316 | 5 | EFO_0022317 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 2.57e-04 | 53 | 316 | 5 | EFO_0022258 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.76e-04 | 239 | 316 | 10 | EFO_0008317, EFO_0020945 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 2.81e-04 | 54 | 316 | 5 | EFO_0022244 | |
| Disease | urate measurement | SYCP2L ABCA1 ADGRV1 SLC22A7 FZD9 NEO1 NRXN1 PKHD1 DDHD2 RFT1 VPS51 CNTN2 PDZRN4 HNF1A POLE DDR2 TEX14 CUBN IGF2BP2 MAP4K5 LRP1 HSD17B11 | 2.90e-04 | 895 | 316 | 22 | EFO_0004531 |
| Disease | vitamin D measurement | TDRD15 ABCA1 SNX27 COG5 PCSK9 COPB1 APOB LDLR CYP2R1 MAP4K5 HSD17B11 DNAH11 | 3.01e-04 | 336 | 316 | 12 | EFO_0004631 |
| Disease | cortical surface area measurement | DCHS2 CPAMD8 RELN ERBB3 CNNM2 SAMD9 MYCBP2 SLC25A26 ADGRV1 PLEKHM1 FZD9 NEO1 ARHGAP31 PKHD1 ADAMTS20 TLN2 PDZRN4 CBLN3 ANK3 COPB1 SLC27A6 NSF FAT3 CACHD1 DENND3 RASL11B CDH11 SNTB1 DNAH11 | 3.01e-04 | 1345 | 316 | 29 | EFO_0010736 |
| Disease | triglycerides in very large HDL measurement | 3.06e-04 | 55 | 316 | 5 | EFO_0022324 | |
| Disease | phospholipids in medium HDL measurement | 3.06e-04 | 55 | 316 | 5 | EFO_0022295 | |
| Disease | Autism Spectrum Disorders | 3.09e-04 | 85 | 316 | 6 | C1510586 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 3.20e-04 | 120 | 316 | 7 | EFO_0004611, EFO_0004639 | |
| Disease | Hyperlipoproteinemia Type IIb | 3.21e-04 | 13 | 316 | 3 | C1704417 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.26e-04 | 200 | 316 | 9 | EFO_0004611, EFO_0020945 | |
| Disease | brain measurement, neuroimaging measurement | DCHS2 ERBB3 IPP SLC25A26 NEO1 ADAMTS20 ANK3 COPB1 SLC27A6 FAT3 DENND3 CRMP1 RHPN2 PRPF3 RASL11B DNAH11 | 3.27e-04 | 550 | 316 | 16 | EFO_0004346, EFO_0004464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EELQLLQEQGSYVGE | 61 | P62195 | |
| LTQLTEILSGGVYIE | 136 | P21860 | |
| IGESLNIGVVQTAYA | 316 | O95394 | |
| VYDQQGIFLLVGTAE | 481 | Q8NDM7 | |
| ITTEGNIIVYGNTID | 831 | Q8NHU2 | |
| AITEVNVYGSGTLVL | 116 | P09564 | |
| NVYGSGTLVLVTEEQ | 121 | P09564 | |
| AIYSGEVNQVIADLI | 186 | Q4G0S4 | |
| TAKYTEGGNAILENI | 1216 | P13569 | |
| GAIRINTQEYLDVLG | 456 | Q9NY47 | |
| TNVYEDALGLGLVVT | 486 | Q9NY47 | |
| LVQTLGEGAYGEVQL | 11 | O14757 | |
| YGESNVNLVIGSEQD | 201 | Q6QNK2 | |
| DSVNEQILALITYTG | 2736 | Q8IZF6 | |
| NQGIEDYGVSITTLN | 771 | Q8IUA7 | |
| IDGVLQRANSTEYGL | 841 | Q3SY69 | |
| VDGLALNFYEGQITS | 916 | O95477 | |
| YQEGLRSLSQEGVAV | 131 | Q9NRW3 | |
| EGTGVEANATQNIYI | 321 | A8K2U0 | |
| QTAVGLELLAEAGNY | 236 | Q9BZE3 | |
| DVEYGTIEGLITTNV | 161 | Q04771 | |
| TISQIETDGINYLVD | 1611 | Q8WXG9 | |
| GLTTLAQAVQAGYEV | 16 | P30043 | |
| IDSGADINLVDVYGN | 126 | Q9BXX3 | |
| GLSNIIGIIVYISAN | 146 | O60359 | |
| GIVGVDVNLAYILED | 481 | Q5VU97 | |
| VFQITLTEGYGIQEL | 2876 | Q96DT5 | |
| VGATIYFDNLQSGEV | 56 | Q09666 | |
| DQDLYIVINGGVEET | 156 | P51648 | |
| LAEVLQQAGYVTGII | 121 | Q96EG1 | |
| YLGTFGELSNVEQVV | 931 | Q12882 | |
| KAGQTLQAELLVVYG | 176 | Q9Y2X7 | |
| QLLGQEDYEVALSVG | 461 | Q92624 | |
| VEETITGDYALIING | 746 | Q8TF62 | |
| IGEEQAGIAETLQYI | 461 | Q9H9F9 | |
| YGAILQGVDSLVLES | 106 | Q9Y259 | |
| IGDVSILVNNAGVVY | 111 | Q8NBQ5 | |
| DGLVLINIDHGSITY | 281 | A2RUS2 | |
| GVSIYQVVAIDLDEG | 906 | Q9H251 | |
| TLTIQGIRFEDNGIY | 106 | P40259 | |
| YEDVSSQSEQGLLLG | 146 | Q14004 | |
| SDQVVLVGTEEGLYA | 1601 | O14578 | |
| SAQALELQGLGVDVY | 86 | Q03468 | |
| ELQGLGVDVYDQDVL | 91 | Q03468 | |
| QAVLTLYAQGLLTGV | 141 | P61160 | |
| VETFENISYGIGLSV | 976 | Q96BY7 | |
| NISYGIGLSVASQLI | 981 | Q96BY7 | |
| EINVQGTRTVIEYSG | 786 | P59510 | |
| IAYDNIVLVLDITSG | 1316 | Q149M9 | |
| QDDIDGIQAIYGLSS | 251 | P22894 | |
| LVEARYQQLEGAGTV | 121 | Q6P1R3 | |
| LAVAGGVVNSALYNV | 16 | P35232 | |
| GSVELQYNESLVSGE | 596 | Q6ZMN7 | |
| EIIVNSGDGIDYSQQ | 241 | Q96M98 | |
| GVYDIVNNLGSLVAR | 276 | Q96AA3 | |
| LLDFIYTGIVNIGVN | 91 | Q9Y573 | |
| GLYINEDNVGLVIQT | 1926 | Q14573 | |
| LLYVGQSAAAIGANV | 976 | O15438 | |
| YIINIQAIEGGSLSG | 261 | Q96TA0 | |
| VYTGRLTITQGNVEA | 91 | Q0D2K2 | |
| NGEIYVIGGTTLDVV | 376 | Q0D2K2 | |
| LGYDTVQVGGISDTN | 146 | P0DJD9 | |
| DQVGDLDISYINIEG | 381 | Q8N1W1 | |
| LVTGITALNSIEGVY | 531 | Q9UJX4 | |
| GYQGVIETLLQNGAS | 576 | Q96NW4 | |
| GLSNIIGIIVYISAN | 146 | Q9Y698 | |
| SAQALELQGLGVDVY | 86 | P0DP91 | |
| ELQGLGVDVYDQDVL | 91 | P0DP91 | |
| FSQLIYSITEGNIGE | 1911 | Q14517 | |
| DIGQYLLNVSVTDGK | 3606 | Q14517 | |
| LTQGGVEFQDVVLAY | 1241 | Q5T3U5 | |
| AYALLQEQTGGIIDA | 491 | Q96AA8 | |
| VVSYGVSLENAVLDQ | 261 | Q9NPJ1 | |
| ELVVGNTQATNLYGL | 191 | Q6IF63 | |
| DDYKVTSQVLGLGIN | 61 | P49137 | |
| AIRDYVNSLLVQGGV | 376 | P42166 | |
| LYLQVASIGASGAQV | 951 | Q7RTR2 | |
| LEIQGITREQSGDYE | 186 | Q9P121 | |
| YAEADIVNLQGVTGG | 521 | Q16832 | |
| QILEILNSTGVEYET | 266 | O76003 | |
| VLTGDALLELNYGQE | 1186 | Q13201 | |
| SGNYTVLQVVEALGS | 41 | Q96T76 | |
| ITIVENVGSVEGLAY | 2276 | Q07954 | |
| IGTDGQVLNLVQSYV | 2656 | Q5SZK8 | |
| LGEDVIVNDELYLNG | 326 | Q9Y5P6 | |
| YLDGSGAQTLVNTEI | 401 | O75197 | |
| AGLQGVVVLEQYRTE | 1611 | O15054 | |
| YLVDLLSNGGQFTIV | 71 | Q5H9U9 | |
| AIGYVTGDGNILQTI | 296 | Q13191 | |
| IGNTVADRGYGIALQ | 761 | O43424 | |
| GGSLVEVYLLDTSIQ | 176 | Q8NBP7 | |
| VASTENGIIFGNIVY | 791 | P53618 | |
| IISELVQTVSLGGNY | 321 | P04066 | |
| VQTVSLGGNYLLNIG | 326 | P04066 | |
| LQRGVNEDTYSGILD | 256 | Q9H936 | |
| VESVLYVGAILEQGD | 376 | P55259 | |
| VQVNEVYGLVDGLVT | 176 | P25021 | |
| RNGDYLDVGIGQVSV | 476 | O94830 | |
| GFNYIIGGSVINELI | 161 | Q9BUN8 | |
| SLYSQLGQEVVAILE | 91 | P52848 | |
| YALLQEQVGGTLDAE | 516 | Q5VZ66 | |
| QGLSVIDTYLVEVDG | 401 | Q8IUZ0 | |
| AQGLGSNLVTEVRVY | 251 | P20823 | |
| VQTGISTDTIYLLEG | 356 | P50748 | |
| LLNGLDYTVDSNLGI | 326 | Q969G2 | |
| GLSIGQEIEVSLYTF | 71 | P46459 | |
| YDIILIETVGVGQSE | 236 | Q8IVH4 | |
| NQYDLLGQTVDSGIV | 216 | P14867 | |
| VQGDIQELYDTTLAL | 161 | Q9H1C3 | |
| LYGLQADITISLDGV | 256 | Q8WTR4 | |
| NYLLTTAENELGVVV | 141 | Q9Y3B2 | |
| LIGIQDGYLSLLQDS | 91 | P63241 | |
| AYALLQEQVGGTLDA | 501 | Q96N16 | |
| LNLGVEIDEINVYGN | 226 | Q8N8A2 | |
| DGQGYLITNREIVSE | 301 | Q07864 | |
| EVLDGLLAQYGTVEN | 96 | Q9Y6M1 | |
| VYLGITTTNGEDVAV | 31 | Q8N752 | |
| IIVAAETAGNGLYNF | 721 | Q6UVM3 | |
| EAASILQELQVETYG | 161 | O00232 | |
| GLEYNEVNVTLDLGQ | 136 | O15230 | |
| LILYNSGDGNDFIVV | 941 | Q9ULB1 | |
| YVGGLSQDISEADLQ | 11 | Q76FK4 | |
| EGINAEIIYAFINIG | 271 | Q9Y5G1 | |
| ARGINIAIVNYVTGN | 106 | P58499 | |
| TYGTIAAIGEQNEER | 146 | O95672 | |
| GLVSARNGYQGLVDE | 1451 | Q86VI3 | |
| GIFEQLGAYIQESAT | 41 | O95140 | |
| LYLSQTDGIQKIIGE | 496 | Q9NPH5 | |
| IVQQDLDYVTELTGA | 346 | Q9BRP4 | |
| LGYDTVQVGGISDTN | 146 | P0DJD8 | |
| LVEVTQSLGFYLGNV | 876 | P78509 | |
| NQGVLLEYSVNGGIT | 2591 | P78509 | |
| LSFVRNGVTLGVDQY | 461 | Q96RW7 | |
| NGVTLGVDQYLKESA | 466 | Q96RW7 | |
| YGELILENVVLEDSG | 4221 | Q96RW7 | |
| ELTLVEYGNNDTLGS | 416 | Q9UG01 | |
| GVDVIAALDLYVEQG | 1411 | Q9UG01 | |
| YLIIQLNTNSIIGDG | 301 | Q92729 | |
| INVLATDQDSGIYGT | 791 | Q6V1P9 | |
| TIESYSIIIQATDGG | 311 | Q9Y5F2 | |
| EDLEGYQNTIVAGSL | 216 | O75400 | |
| QEVARIVGNSGLNIY | 261 | P10619 | |
| QVTVYINRGNGALEE | 336 | Q13797 | |
| DGSILASYGNVIVIT | 186 | Q8NFZ3 | |
| NGEITYEILVGAQGD | 541 | Q96QU1 | |
| DYLSQGIDLSGIEVI | 211 | Q9UP83 | |
| VVIVNQTYGILESIG | 1281 | O60494 | |
| EYLISDTGGQQLSIS | 546 | Q9Y2I7 | |
| TLDGGELIVNYRAQA | 151 | Q96C23 | |
| QEAGALYVIQEGLEN | 296 | O00144 | |
| LYVIQEGLENTGCTL | 301 | O00144 | |
| VVDLLSYNVQGSGET | 1396 | P04114 | |
| GVQVEGLTVQYLGQA | 101 | O75173 | |
| IVLDGTDNQYLGLQI | 581 | P42858 | |
| SGDVYVERVQGNSVL | 91 | Q93033 | |
| LIGIQDGYLSLLQDS | 91 | Q6IS14 | |
| LTFGQLEQNVYGITI | 106 | P40189 | |
| YTAEIVVGEGNVQTL | 151 | Q6TDP4 | |
| LINTGVLSVGADQYL | 361 | Q8NB78 | |
| VVGGYDGQNRLSSVE | 411 | Q6TFL4 | |
| ELGYDALLVGTQTNL | 86 | Q9BXC9 | |
| QYFTESGLVGLLEQA | 1721 | Q8NF50 | |
| EGDITQILNSLLQGY | 61 | Q8N1C3 | |
| TEGTNYEQLVVDAGV | 61 | P01133 | |
| GIDYDISVITLINGG | 1331 | P02751 | |
| LGGISTVVLNGYDVV | 81 | Q6VVX0 | |
| ISGVVQSYVELGLNE | 201 | Q13616 | |
| IGEGEQEAQITYIDS | 561 | Q14CM0 | |
| LIENYQTVVIVGETG | 66 | Q9H5Z1 | |
| QETGDIVISNAYVDL | 591 | P51659 | |
| YVLILDEEGGTTNDQ | 441 | Q8ND61 | |
| DGENLEIQSYSLIGE | 2311 | Q8N3K9 | |
| YEVAARGNIVLSGQQ | 486 | Q8IZJ3 | |
| DIYVIGLQELNSGII | 46 | Q9BT40 | |
| EDGDSIQVGLVQYNS | 1671 | P12111 | |
| IIEIAISSGQYGEGV | 1101 | Q96RY5 | |
| YSVNILESSGIGTEI | 836 | Q8TDW7 | |
| GENAELIYTIEAGNT | 1596 | Q8TDW7 | |
| IDLGISFQIYVLQAG | 501 | Q13617 | |
| ILEQTDIQGALSAYG | 421 | Q6PD62 | |
| SGTGTLQIYLIDIND | 596 | P55283 | |
| DIGENGLVTYNIVDG | 296 | P55287 | |
| QVSGVLGIEDYSVSQ | 2336 | Q9BZC7 | |
| IDGIIFAANYLGSTQ | 456 | Q02410 | |
| SGQAEVVRYLVQDGA | 476 | Q12955 | |
| LEYGADANAVTRQGI | 651 | Q12955 | |
| PAETYALVGQQVTLE | 246 | Q02246 | |
| EIGEELINGVIYSIS | 66 | Q12967 | |
| VRVAQSLQGEQIGSY | 471 | O75578 | |
| QVTIDGRNYIVDAGS | 111 | P11245 | |
| EGNSTYSEEQLLGVQ | 61 | Q9H819 | |
| DVLLSGQQDDGVYSV | 246 | Q8N539 | |
| YNGRVVGEAQVQSLD | 226 | Q00978 | |
| GTSGAIYFDQVLVNE | 91 | Q6UW01 | |
| ILYLINQGEHLGTTE | 51 | Q9Y678 | |
| IVENVNVIISTYGEG | 181 | P13639 | |
| INSVDGNYIGQVLVT | 521 | Q05BV3 | |
| LEGDVQRLAQTYGTL | 186 | Q9NT22 | |
| VDILVNNAGISYRGT | 136 | Q6IAN0 | |
| DNQYTLFVAGGTVLL | 246 | Q15762 | |
| QLAYQVLGLSEGATN | 276 | Q8N4W6 | |
| QVTYLRQIVTAGLGD | 921 | Q8IY37 | |
| LDVSGLGLNVYQTQL | 366 | Q9Y694 | |
| QIFSNILYEEGIQGL | 126 | Q70HW3 | |
| AILSLGGIAYIQQNV | 206 | Q8N697 | |
| GQISNYVVAFILGTE | 206 | Q9H015 | |
| TGQYLALTEDQGLVV | 286 | P21817 | |
| YTINGVSVEDTINLL | 2106 | Q92736 | |
| DGSILASYGNVIVIT | 186 | Q8N0W4 | |
| TQLDGVEGLQGVYVL | 966 | O43933 | |
| SGTGTLQIYLLDIND | 586 | P19022 | |
| QIVAGVNYFLDVELG | 81 | P01034 | |
| DGSQYFVLLIVTDGV | 431 | Q86YQ8 | |
| GGRIINDDQSLYADV | 21 | Q14194 | |
| YTLVVQAADLQGEGL | 341 | P12830 | |
| DIYSVGIGDVDDQQL | 1131 | A6NMZ7 | |
| AAVQDGSQYSVLLII | 446 | Q9HCH3 | |
| EANAGQLYLTGVVVL | 561 | O43395 | |
| VNGTLLDGTQVLKIY | 516 | Q6UXK5 | |
| LQGNNEAYAELIVLG | 226 | Q86X29 | |
| IFGTEDGIYTLNLNE | 526 | Q9Y4K4 | |
| LGYLTVGEQSEELVT | 1346 | Q5THK1 | |
| LGYDTVQVGGISDTN | 146 | P0DJD7 | |
| DFNLLEQTETLGVGY | 1211 | Q16363 | |
| STAVVNSEIYVLGGI | 486 | Q3ZCT8 | |
| QGQADSLTVYLVVAL | 681 | Q9UN66 | |
| TTYVEQVQEELGELG | 341 | Q9H0X9 | |
| YSGINLAVLLIVAGQ | 401 | Q6ZN16 | |
| VVLTENAVYTFGLGQ | 256 | Q92834 | |
| TPISILYIDAGNNVV | 426 | Q6KF10 | |
| SVADLQQIADGVYEG | 961 | Q9Y4G2 | |
| AGNLYTRQVQIEGET | 66 | Q9BPW5 | |
| LKVLYNDLGAQVTEG | 1521 | P46939 | |
| TQALYVGDAILSVNG | 151 | Q13884 | |
| GLLENNGLVGYAQEV | 341 | Q9NQ86 | |
| IYEAVLLQTPTQAGE | 336 | P49590 | |
| ELQGEVVIIITDQYG | 1166 | A6NHR9 | |
| GIYVDAVNSLGQTAL | 46 | Q8IWB6 | |
| YLLSAGQDVQGTSVI | 61 | Q6NUP7 | |
| GVANYALVSVLNLGV | 231 | Q86VL8 | |
| ATGLIQYALDQGVNV | 121 | O75792 | |
| EAERNLLENGSVYVG | 26 | Q9H061 | |
| LLENGSVYVGLNAAL | 31 | Q9H061 | |
| GSGQQVHYETLALEL | 4561 | Q8WXH0 | |
| ILSQESDGQLGIELY | 1111 | B5MCY1 | |
| STGLYLLEGQNAEVS | 546 | A6NFQ2 | |
| VTIYALGVGDQALID | 286 | A0AVI2 | |
| LNQISSTGEEIEGVY | 411 | A0AVI2 | |
| LGYTQTNVGEALAAV | 146 | P28069 | |
| LLEAGINVTVYNGQL | 356 | Q9HB40 | |
| EQYGQILLSEEVTGL | 31 | Q8IVG5 | |
| SEIGEQVTSLITYGA | 771 | Q5K651 | |
| GYRVDSNQELVALGL | 371 | Q9BXS9 | |
| GYQVDGNQELIALGL | 366 | P58743 | |
| SLVNEYDDNGEGIIL | 191 | P30101 | |
| ETGLDAGLQELSYLQ | 191 | Q9NXK8 | |
| YILEVQAVNGVSELS | 456 | O15197 | |
| GAYQANILVEDATIG | 456 | Q9NXP7 | |
| RELIQEYGAQSGGLE | 1811 | P58107 | |
| QLSQLIEGLDRGTEY | 691 | Q92859 | |
| QGIGLASVVIESYLN | 116 | P48065 | |
| GYLLQVQELVTVQEG | 26 | Q9NYZ4 | |
| TQVGVALGDLQASVY | 251 | Q9UHJ6 | |
| QTLSLLVQEEGYGSL | 266 | Q96CQ1 | |
| HAQVGSLYIVLGELQ | 66 | Q86WV5 | |
| IQSKGGLDEALYNVI | 746 | Q93073 | |
| DGELADLGQYSINVT | 116 | A0A087WV53 | |
| TEGQNILFTDGEYIN | 456 | O75592 | |
| LRQLTYLVSGEGQVQ | 2696 | P08F94 | |
| DNVGAGYLALLQVAT | 1401 | Q9NY46 | |
| VGIDGEVLSYLELAQ | 591 | O94844 | |
| GYGIEIQVQTLNLSQ | 211 | Q6UXD5 | |
| YLQEGSQGDIALLQL | 126 | Q16651 | |
| ILINDVLTAANGAYV | 191 | Q9NTN3 | |
| AVLLNLGTIELYGSN | 661 | Q5T5C0 | |
| LEGLNISVGVYQNTE | 91 | Q8IUC4 | |
| QVSTYQEVIRGEGIL | 281 | O43556 | |
| GYEQLALGVTQILLG | 61 | Q3YBM2 | |
| NLEELQGSGVDYILN | 326 | Q8WYL5 | |
| QGSGVDYILNVTREI | 331 | Q8WYL5 | |
| LLGNGSLIYQVQVVG | 431 | Q9H2X0 | |
| GQLAVVADDGITQYA | 391 | Q8IV77 | |
| LLDCVLGQEIGTVYN | 396 | Q9H8M5 | |
| NGQIILLKGYSVDVD | 751 | Q9BXU1 | |
| ELQSFVGAVIVGTYN | 616 | P48995 | |
| LVQEVELNIVAGYGS | 1111 | O00562 | |
| TAIDVQVGLLYEEGV | 621 | Q9UID3 | |
| GTGEVIVQNYNSILT | 176 | Q9UJT1 | |
| TVQDAGLYQGQVLVI | 201 | Q13107 | |
| ASLEIEYQVLDGAGL | 56 | Q9Y3A6 | |
| VSKIIAENIYEGGLN | 111 | O14656 | |
| QLDYNSVGDIGVEQL | 796 | Q9HC29 | |
| NYITAAGAQVLAEGL | 881 | Q9HC29 | |
| VAVDSLNGLVYIGQR | 66 | Q5JS37 | |
| YTVVLGLGELLQDFQ | 526 | Q86WA9 | |
| VLETYGLTEGNVATI | 421 | Q5K4L6 | |
| SNLLGYIGIDTIIEQ | 36 | Q9UH03 | |
| QTTEGEQIAQLIAGY | 381 | Q9Y490 | |
| YAVTGAVLGQDRLIN | 516 | Q8TB22 | |
| LLTVGDYDQQVAISE | 221 | Q5T4T6 | |
| DGAIQITTDYEILTI | 646 | Q92545 | |
| DNVGLGYLSLLQVAT | 1406 | Q99250 | |
| SDYSGQGVDQLQRVI | 151 | P04818 | |
| STIQDAGLYQGQVLV | 196 | Q9Y4E8 | |
| ISAAAVLGIIYDNQV | 181 | Q71RS6 | |
| VESAYSQLGQEIVAI | 91 | P52849 | |
| QIEFVLTSVGYAVGL | 106 | P48067 | |
| SIVVFGSIVNEGYLN | 36 | O43759 | |
| YGITSLQQEGEELSG | 151 | Q9H3T2 | |
| VSEGGQLRSINGELY | 61 | Q96L92 | |
| ENTEILGYLLGSVAA | 176 | Q2T9K0 | |
| QVLTLATEQTYAVEG | 136 | Q9HBU9 | |
| VDGIYRLSGVTSNIQ | 51 | Q2M1Z3 | |
| LEGLNISVGIYQNTE | 6 | A8MT19 | |
| GYEVVEGNNVTLDIT | 611 | Q86WI1 | |
| EISNAIDQYVTGTIG | 486 | P31939 | |
| AAGEGLNVIQQTTRY | 196 | Q8N7R0 | |
| TEGEQISQLIAGYID | 386 | Q9Y4G6 | |
| EEIAYQVAGVSGNLA | 1631 | Q9UL36 | |
| GLVANVITAGDYDLN | 101 | Q9Y2L5 | |
| QVSYLEVGRIQTEEG | 521 | P52739 | |
| EGYTIIGVEQTAKSL | 1536 | Q13395 | |
| EVYLGLQQFIVTSGS | 521 | Q96QU8 | |
| GDVYLNTGDLIVQDQ | 456 | Q9Y2P4 | |
| LISLYENGINGILAD | 191 | O60264 | |
| YGQIVEELSAVELTN | 1466 | P31629 | |
| DTLGGATIIYQQGAE | 771 | Q9H4Z2 | |
| EQVLDVETGNEYGNL | 181 | O43309 | |
| AVVEEITGYLAVNGV | 191 | Q8IYH5 | |
| ISERNQDATVYVGGL | 6 | Q15427 | |
| AVLYVGEGQSNSELA | 1546 | P49815 | |
| YIETSIGEGANVVSL | 286 | Q8NDX2 | |
| IDLLQVEGYNLIAAG | 651 | B1ANS9 | |
| VEGYNLIAAGTLNGV | 656 | B1ANS9 | |
| YRVIQVSEGQLDGQT | 61 | P22415 | |
| VSIGNSVGYENIISD | 1236 | Q5THJ4 | |
| RQVTALQEEGTLGLY | 2616 | Q14789 | |
| GLNGVDIYSLVTENI | 546 | P01130 | |
| IETQLYVIVAQLFGG | 291 | O95970 | |
| SGSEVIVGVNKYQLE | 481 | P22033 |